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Bis(methidium)spermidine (BMSpd), an analog of ethidium bromide in 
0 
which two phenanthridine chromophores are tethered by a 10 A spermidine 
linker, has been synthesized and characterized in order to test the effect of 
linker length on DNA binding. Like bis(methidium)spermine (BMSp), 1 a dimer 
0 
with a 15 A tether, BMSpd unwinds DNA 36.50. Unlike BMSp, the binding of 
BMSpd to calf thymus DNA, poly dG·poly dC, poly rA·poly dT, and poly 
dA ·poly dT is complicated. At 0.4 M ( M+) and pH 7, the binding site sizes 
and binding constants of BMSpd range from 2.7 5 base pairs (calf thymus DNA) 
to 4.0 base pairs (rA·dT, dG·dC) and 5 x 105 M-1 (dA·dT) to 6 x 106 M-1 
(r A ·dT). These affinities are on the average, ten times higher than the 
analogous affinities of ethidium bromide and 300 times less than the binding 
constants of BMSp. The most dramatic change occurs in the binding 
specificity of BMSpd. Whereas, BMSp binds poly r A ·dT 1440 times more 
tightly than poly dA ·dT, the spermidine analog (BMSpd) binds poly r A ·dT only 
10 times more tightly than poly dA ·dT. 
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Part II 
The ethidium dimers, bis(methidium)spermine (BMSp) and 
bis(methidium)spermidine (BMSpd), were found to site selectively inhibit 
DNase I and a variety of restriction enzymes on the plasmid pBR322. In 
contrast to the dimers, the monomer, ethidium bromide (EB), shows no site 
selective action · in competition with any of the enzymes tested. The sites 
preferentially inhibited by BMSp and BMSpd appear to be in the first third of 
the plasmid. These observations and the clustering of inhibited restriction 
sites then suggests that selective inhibition may be due to the recognition or 
perturbation of DNA secondary structure. 
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CHAPTER ll 
The compounds methidiumpropyl-EDT A, distamycin-EDT A, and penta-
N-methylpyrrolecarboxamide-EDT A are three representative examples of a 
class of rationally designed DNA cleaving agents. By appending an iron 
chelator to different DNA binding vehicles certain properties of the resulting 
DNA cleaving agent can be controlled. Methidiumpropyl-EDT A randomly 
single strand cleaves DNA with high efficiency. Distamycin-EDT A nicks at 5 
base pair recognition sites, and penta-N-methylpyrrolecarboxamide-EDT A 
double strand cleaves DNA at 6 base pair recognition sites. The success of 
these compounds led to the design of a controlled site cleaving agent, 
oligonucleotide-EDT A. 
The construction of the molecule was approached in two ways, 
synthetically and enzymatically. Synthetically, the oligonucleotide-EDT A 
was constructed by known nucleotide triester methodology. Enzymatically, a 
modified uridine, EDT A-dUTP, was incorporated into a DNA fragment. 
Unfortunately, neither strategy yielded an active DNA cleaving agent. These 
failures, however, do not directly reflect on the viability of an 
oligonucleotide-EDT A. It is possible that an extended research effort will 
uncover the methods needed to create an active oligonucleotide-EDT A. 
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CHAPTER I 
Bismethidium Intercalators: 
The Binding of Nucleic Acids 
- 2-
Part I 
The Binding Properties of PolyintercaJators 
-3-
A. Intercalation 
Acridines, phenanthridines and other small organic compounds 
characterized by a planar aromatic structure have been shown to bind to 
DNA (Fig. 1);2-8 the binding of these compounds induces a distinctive set of 
changes in the macromolecular properties of the DNA. The sedimentation 
coefficient of the DNA decreases,9 and the intrinsic viscosity increases.lO 
The superhelicity of closed circular DNA increases, 11 and the microscopic 
contour of the nucleic acid helix lengthens.l2 
Observation of the bound chromophores by dichroism 9 and NM R 13 
suggest that the molecules are bound perpendicularly to the helix axis of the 
DNA and that there is considerable electronic interaction between the bases 
of the DNA and the aromatic chromophore of the DNA bound effector. 
These data are consistent with binding by intercalation, the insertion of the 
aromatic molecule between the base pairs of the nucleic acid helix; 14 
moreover, So bell's dinucleotide crystal structures 15 lend structural evidence 
for this mode of binding (Fig. 2). 
Ethidium bromide (EB)l6-20 is one of the best characterized 
intercalators. The association of EB with DNA is accompanied by an 
enhanced fluorescence yield from the chromophore and a red shift of the 
visible absorbance maximum;9,12 consequently, the binding of EB to DNA is 
easily monitored by fluorescence and absorbance. Both equilibrium and 
kinetic studies reveal two bound species of EB: (1) an intercalated species 
and (2) an outside bound species.16 The outside bound species is simply an 
electrostatic coupling of the EB cation to the DNA polyanion. 
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1.0 EB per base pair of DNA and exhibits little enhancement in the 
fluorescence yield. Conversely, the intercalate saturates at levels less than 
or equal to 0.5 an EB per base pair and is distinguished by a 20 fold increase 
in the fluorescence yield.9,21 It is this intercalative mode of binding that is 
of interest. 
Investigations, that utilized both synthetic and natural DNA's as 
substrate, have shown that EB is not base specific9 and have provided 
evidence that EB is instead "conformationally" selective.! ,7 ,16 EB binds the 
DNA/RNA hybrid rA·dT 100 times more tightly than dA·dT (Table 1);16 
furthermore, the RNA/DNA hybrid and the DNA saturate at different 
stoichiometries in 1 M Na+ solutions. The DNA complex exhibits nearest 
neighbor exclusion (1 EB/2 bp), while the hybrid saturates at one EB per 3.0 
base pairs.l 
This behavior can then be used as a basis to speculate that differences 
in the binding of EB to defined synthetic DNA's are a reflection of the 
conformational variations of different DNA sequences and that EB can induce 
conformational changes in the receptor DNA to allow intercalation. 
B. Polyintercalation 
Whereas, the conformational selectivity of EB is remarkable, its 
inherent DNA binding affinity is unspectacular.l6 This problem of moderate 
DNA affinity characterizes many interca1ators.16,22 The natural product, 
echinomycin, intercalates tv:o chromophores simultaneously .23 Severa.i 
researchers pursued nature's example and synthesized sets of acridine, 
phenanthridine, and mixed acridine-phenanthridine dimers.24-27 Examination 
-7-
of these compounds demonstrated that the DNA affinity of a dimer is 
substantially higher than the DNA affinity of the respective monomer. In 
many cases the dimer binds DNA so tightly that binding constants can only be 
estimated. 
More importantly, the ability of a dimer to bisintercaiate is 
dependent on the maximum separation of the tethered monomers, and the 
critical length is dependent on the nature of the linker connecting the 
chromophores. Polyamine linked dimers exhibit neighbor exclusion, while 
hydrocarbon linked dimers bisintercalate nearest neighbors. 8,24 This implies 
0 0 
bisintercaiative separations of 10 A and 7 A for the polyamine and 
hydrocarbon linkers, respectively. Consequently, these structural parameters 
were considered when the synthesis of a phenanthridine dimer, bis-
(methidium)spermine, was conceived.! 
0 
The molecule synthesized was a spermine linked ( 15 A) analog of 
ethidium bromide, designated bis(methidium)spermine (BMSp).28 What 
became critical to any analysis was the realization that the interaction of the 
cationic BMSp with the anionic DNA could be treated as a polyelectrolyte 
problem.29,30 By working in buffered 1 M Na+ solutions the electrostatic 
contributions to the DNA binding affinity could be minimized thus allowing 
BMSp binding constants to be measured directly.? 
The bisintercalation of BMSp is found to be 1.6 times more 
energetically favorable than the intercalation of EB. In addition, the r A·dT-
dA·dT selectivity climbs from a ratio of 100 for ethidium to a ratio of 1440 
for BMSp (Tables 1 and 2) where it has been suggested that this selectivity is 
due to conformational recognition.? ,16 
Table 1 
EB 
Nucleic (M+] K y Site Size Acid 
Colt Thxmus 
ON 1.0 4.5x 10
4 0.1-0.5 2 
Poly dG·dC 1.0 I X 105 0.1-0.3 2 
! 
Poly rA·dT 1.0 2xl05 0.1-0.3 3 
Poly dA·dT 1.0 2xl03 0.1-0.4 ( I ) 
BMSp 
[M•] K y 
1.0 1.5 X 107 0.1-0.2 
1.0 2.6 X 108 
0.05-
0.15 
1.0 2.3 X 108 0.05 






















dAdT 100 1440 
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Whatever the molecular explanation, the data show three intercalated 
species: (1) A low affinity intercalation covering an undefined site, (2) a high 
affinity intercalation of DNA covering 2.0 base pairs per chromophore, and 
(3) a high affinity intercalation of DNA and RNA/DNA hybrids that excludes 
3.0 base pairs per monomer. By exploiting these three intercalated forms the 
specificity of a potential bisintercalator might be predictably altered by 
simply changing the length and flexibility of the linker joining the two 
intercalating chromophores. As a result, a shortened dimer, bis(methidium)-
spermidine, has been synthesized; the binding constants to a variety of 
0 
nucleic acids have been determined, and the 10 A spermidine linked bis-
o 
intercalator has been compared to the 15 A spermine linked dimer. 
C. Results and Discussion 
l. Synthesis. The rationale for the synthesis of an ethidium dimer 
0 
with a 10 A linker (spermidine) is based on the observations that linker length 
is important in determining the ability of a compound to bisintercalate and 
that at least two of the three intercalated species exhibit different binding 
stoichiometries. A linker long enough to allow bisintercalation at 1.0 
molecule per 4.0 base pairs may not be long enough to allow bisintercalation 
of an RNA/DNA hybrid at 1.0 molecule per 6.0 base pairs (Fig. 3). This 
implies that one might be able to substantially alter the selectivity of an 
ethidium dimer by reducing the length of the linker. 
The synthesis of the 10 ~ dimer, bis(methidium)spermidine (BMSpd), is 
based on the synthesis of bis(methidium)spermine (Fig. 4).1 Two equivalents 
of p-carboxylmethidium chloride! were coupled ·o the primary amines of one 
-11-
equivalent of spermidine. The reaction was chromatographed twice on silica 
gel, and the isolated solids were repurified on AG50W -X8 cation exchange 
resin. The resulting sample proved to be analytically pure. 
2. Physical Properties. BMSpd is a water soluble trication at 
0 
physiological pH. The short, 10 A, linker does not significantly change the 
solution behavior of the dimer. It is similar in many respects to BMSp. Like 
BMSp, BMSpd shows ultraviolet and visible absorptions characteristic of a 
phenanthridine chromophore. Both molecules exhibit intramolecular coupling 
of the tethered chromophores which leads to a visible absorbance that is red 
shifted with respect to EB and reduced in relative intensity. The visible 
maximum of BMSpd occurs at 501 nm (Fig. 5), 22 nm red shifted from the 
visible maximum of ethidium, and although the position of the visible 
maximum is independent of ionic strength the molar absorbtivity decreases 
with increasing ionic concentrations; BMSp also shows this same trend in 
extinction coefficient but the effect is more pronounced. This suggests that 
the orientation of the intramolecularly stacked chromophores is more 
constrained in the spermidine linked bisintercalator than in the spermine 
linked bisintercalator. As a consequence, the low salt (0.07 5 M ( M+)) 
spectrum of BMSpd most resembles the high salt ( 1.0 M ( M+)) spec-
trum of BMSp. 
3. Intercalation and Helix Unwinding. Direct evidence for the 
simultaneous intercalation of both chromophores of BMSpd is provided by 
DNA unwinding experiments. Previous viscometric measurements at 0.075 M 
( M+) had shown that the known bisintercaiator, BMSp, unwound DNA 
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Since the time that the BMSp measurements were made, viscometry has been 
superseded by electrophoretic band counting. 31 ,3 2 One can deduce the 
unwinding angle of an intercalator from the number of supercoils induced in a 
closed circular plasmid. 
Unwinding Angle = Supercoils x 360 number of bound intercalators 
Although viscometry is inherently more accurate, band counting is quicker 
and more versatile. Unwinding angles may be determined as a function of 
saturation with band counting, whereas, viscometry returns an average 
unwinding angle at a specific equivalence point. 
Band counting gives unwinding angles for EB and BMSp of 280 ± 
30 (Fig. 6) and 360 ± 3° (Fig. 7), respectively; while, BMSpd exhibits an 
unwinding angle of 36.50 ± 30 (Figs. 8 and 9). The similarity of unwinding 
angles for BMSp and BMSpd suggest a common intercalated species. In the 
case of BMSp this intercalated species has been shown to be a 
"b is intercalation"; correspondingly, BMSpd appears to be capable of 
bisintercalating heterogeneous DNA. 
4. Binding of BMSpd to Double Helical Nucleic Acids. Binding 
affinities of intercalators may be determined by spectrophotometric methods 
when the bound and free forms of an intercalator exhibit different absorption 
or fluorescence spectra. In the case of phenanthridine analogs the visible 
absorbance of the intercalated species is generally red shifted 30 nm from the 
absorption spectrum of the unbound intercalator. Since the visible spectrum 
-16-
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Figure 8. BMSpd Unwinding. 
Lane A: PM2, Lane B: BMSpd/PM2 (bp), v = 0.0238, Lane C: 
v = 0.0202, Lane D: v = 0.0166, Lane E: v = 0.0131, Lane F: v = 
0.0095, Lane G: v = 0.0059, Lane H: v = 0.0000. Total DNA = 2 llg 
PM2, N/C enzyme = 9 units, incubation time: 24 h at 37oc. Electrophoresis: 
18 h at 7 5 V /70 rnA; the nicked/closed PM2 was run as positive super coils in 
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Figure 9 
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is also free of DNA absorptions, absorbance titrations are the preferred 
technique for the determination of phenanthridine binding constants. The 
titration data are most conveniently plotted in Scatchard form,33 and the 
intrinsic DNA binding affinity of the intercalator is read off the experimental 
curve. Additional binding parameters may be extracted by comparing the 
data to the theoretical model proposed by von Hippe! and McGhee,34 where 
neighbor exclusion intercalation can be described by the equation 
\) 
L = K(l-nv)• l-t~~~)v [ J 
n-1 
In this case v is the ratio. of bound intercalator to DNA concentration in base 
pairs, L is the concentration of free intercalator, K is the intrinsic binding 
constant of the intercalator, and n is the binding site size. 
a. Binding of BMSpd to Sonicated CaJf Thymus DNA at 1 M 
( M+). The intercalation of an ethidium phenanthridine involves both 
electrostatic and non-electrostatic interactions. To minimize electrostatic 
contributions previous studies of BMSp and EB were conducted in 1 M 
( M+) solutions. Thus, the binding of BMSpd to sonicated calf thymus 
DNA was first examined at an ionic strength of 1 M ( M+) 
to allow direct comparison to the calf thymus binding constants of EB and 
BMSp. 
The visible absorbance spectra of BMSpd bound to calf thymus DNA in 
1 M ( M+), pH 7, shows the expected metachromic shift of the absorption 
maximum, but the full width of the absorption band at ha.lf height is unusually 
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determining this bound spectra also suggests that the binding affinity of 
BMSpd to calf thymus might be less than 1 o6 M -1. 
The actual titrations confirmed a low binding constant. The data 
yielded Von Hipple/McGhee estimates of the binding affinity and binding site 
size of 3.5 x 1 o5 M -1 and 2.5 base pairs (Fig. 11 ), respectively. The binding 
constant is 10 times higher than EB, but 50 times lower than BMSp; 
furthermore, the small, nonintegral binding site size suggests that mono-
intercalation is competing with the bisintercalated forms. It may be possible 
that only a small number of sites are available to a short bisintercalator and 
monointercalation must occur along the remainder of the DNA helix. 
b. Determination of Binding Affinities at 0.4 M ( M+). Th_e 
difficulty encountered in determining the spectrum of BMSpd bound to calf 
thymus at 1.0 M ( M+) lead to a reduction in the standard ionic strength. 
BMSpd binding constants for a variety of double helical nucleic acids were 
determined in 0.4 M ( M+) solutions in order to avoid the experimental 
problems associated with "low" binding affinities. 
To compare binding constants at 0.4 M ( M+) and 1.0 M ( M+) 
the data may be extrapolated to one salt concentration using the equations of 
Manning29 and Record.30 
-a 1 og K b 
0 s 
= m 'l'' 
where K is the binding constant, ( M+) is the salt concentration, m is the 
number of charges per binding molecule and '¥ is a shielding factor 
Figure 11 
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(0.88 for DNA). Assuming that the polyelectrolyte theory of Manning and 
Record applies to BMSpd as well as it has been shown to apply to EB, the 
BMSpd trication should bind DNA 10 to 15 times more tightly in 0.4 
M ( M+) solutions than in 1.0 M ( M+) solutions.? ,25 
The spectra of BMSpd bound to sonicated calf thymus DNA, 
poly dG·poly dC, poly dA·poly dT, and poly rA·poly dT are generally similar 
and are characteristic of an intercalated phenanthridine (Fig. 12). The 
absorbance maxima are red shifted a minimum of 29 nm from the absorbance 
of BMSpd, and the intensity of the absorbance is slightly reduced. The widths 
of the bands at half height tend to be 10 nm narrower for the intercalated 
species than for the free dimer. An exception is poly dA ·poly dT. The width 
of BMSpd bound to poly dA·poly dT is equal to the width of the free molecule; 
however, this was not unexpected. The red shifts, extinction coefficients and 
peak widths of BMSpd are comparable to BMSp (Table 3). 
Scatchard analysis of the 0.4 M ( M+) titration data reveal BMSpd 
binding affinities and binding site sizes to calf thymus DNA, poly dG·poly dC 
and poly rA·poly dT of 5 x 106 M-1 and 2.75 base pairs, 5 x 106 M-1 and 4.0 
base pairs, and 6 x 106 M-1 and 4.0 base pairs, respectively (Table 4, Figs. 
13-16). These affinities are estimated to be 3 to 10 times greater than EB 
but 50-500 times less than BMSp, and although BMSpd excludes a larger site 
than EB the binding affinities are indicative of either a monointercalation or 
an unfavorable bisintercalation. Even the 4.0 base pair binding site sizes for 
poly dG·poly dC and poly rA·poly dT do not exclude the possibility of a 
monointercalated species. A monointercalated form could block a 4 base pair 
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BMSpd E(M-1 cm- 1) "-max(nm) I/2W (rrn) 
~0 9600 501 -
0.075 M+ 8835 501 101 
0 .40 M• 8820 501 100 
1.0 M+ 8520 501 101 
c. T. 1.0 M+ 6450 532 95 
C.T. 0.4 M+ 7140 530 90 
dG·dC 0.4 M+ 7730 530 90 
rA·dT 0.4 M+ 8160 531 89 
dA·dT 0.4 M+ 8680 533 101 
BMSp 
H20 10160 502 99 
0 .075 M• 9850 502 98 
1.0 M+ 8900 502 97 
4 .4 M+ 8400 502 98 
C.T. 1.0 M+ 7800 530 92 
dG ·dC 1.0 M• 7880 530 92 
rA dT 1.0 M+ 8600 530 89 
dAdT 1.0 M+ 7880 526 98 
EB 
1.0 M+ 6060 480 87 
C.T 1.0 M+ 
4000 520 85 
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BMSpd 
Nucleac (M•) K Sde Size Acid 
Sonacoted 1.0 3 . 5 X 10
5 
2 . 5 Calf Thynu 0.4 5 X 106 
Poly dG·dC 0.4 5 X 10
6 4 
Poly rA ·dT 0.4 6 X 10 6 4 
Poly dA ·dT 0.4 5 X 105 -
Table 4 
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outside of the nucleic acid helix.8-10 
In contrast to the previous nucleic acids, poly dA ·poly dT binds BMSpd 
only 3 times less tightly than BMSp and 25 times more tightly than EB. The 
short dimer, BMSpd, mimics the documented bisintercala tor, BMSp, on 
poly dA ·poly dT. 
Becker and Dervan note that poly dA·poly dT is unique in its binding of 
intercalators. The intercalation constants are anomalously low, and the 
dimer, BMSp, exhibits an exceptionally wide bound spectra. This spectral 
deviation is proposed to reflect nearest neighbor bisintercalation since 
picosecond fluorescence decay shows that both chromophores are 
intercalated.28 If this is the case, BMSpd probably bisintercalates 
poly dA ·poly dT just as BMSp binds the homopolymer. 
Whatever, the molecular phenomenon, however, the specificity of 
BMSpd is different from the specificity of BMSp. The alteration of specificity 
as a function of linker length is illustrated by the ratios of binding constants 
for the various nucleic acids and intercalators. Whereas, EB and BMSp prefer 
the r A ·dT helix over the dA ·dT helix by factors of 100 and 1440, respectively. 
BMSpd binds r A ·dT only 10 times more tightly than dA ·dT (Tables 5 and 6). 
BMSpd is characterized by a relatively reduced affinity for nucleic acids that 
are bound with high affinity by EB and BMSp and a relatively enhanced 
affinity for dA·dT. The shorter linker appears to have severely limited the 
sequences that are available for bisintercalation by BMSpd, but the unwinding 
angle of BMSpd proves that there are at least a small number of sites 
available for bisintercalation on a heterogeneous sequence. The low binding 
constants may be a consequence of a low affinity bL.intercalation, a 
Table 5 EB 
Nucleic (M+) K Site Size Acid 
Sonicated 4 2 Calf Thymus· 1.0 4.5 X 10 
Poly dG·dC 1.0 I X 105 2 
Poly rA·dT 1.0 2 X 105 3 




1.5 X 10 
7 
.. 
2 .6 X 108 
2.3 X 108 




S1te Size K Site Size 
4 
3.5 X 105 
2 .5 • 5.0 X 105 
't 
4 5 X 105 4 
6 6 X 105 * 4 
2 5 X 104. ( 2) 
------ -- --
+ 












C.T. 0 . 23 0 .065 0 .83 --
rAdT 
dGdC 0. 50 1. 13 0 .83 --
rAdT 
rAdT 
100 -- 1440 12 
dAdT 
C.T. 
22 .5 94 10 --
dAdT 
dGdC 50 1630 10 --
dAdT 
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"hanging" monointercalation, or the over saturation of a small number of high 
affinity bisintercalation sites, and the predominence of a "hanging" 
monointercalator at the concentrations of BMSpd necessary for accurate 
optical measurements. 
What possibly remains is the synthesis of a dimer tethered to select a 
4.0 base pair bisintercalation but unable to reach a 6.0 base pair 
bisintercalation. Although such a dimer is very attractive, predictions based 
on the BMSp and BMSpd binding data suggest that such a molecule would only 
exhibit moderate selectivity. This compound would be expected to bind 4.0 
base pair bisintercalation sites as well as BMSp and 6.0 base pair sites with 
the same affinity as BMSpd. In the best case one would predict 
poly dG·poly dC would be bound 400 times more favorably than 
poly rA·poly dT, and in the worst case calf thymus DNA would be preferred 
to r A ·dT by only a factor of 20. 
Although this moderate selectivity may be acceptable, problems would 
arise in the choice of a linker. X-ray crystallographic data35,36 and 
molecular models suggest that the difference of linker length necessary to 
span a 4.0 base pair bisintercalation and a 6.0 base pair site is only 1.6 to 2.4 
0 
A; consequently, there is little margin for error. A linker that would 
discriminate a 4.0 base pair site from a 6.0 base pair site must be chosen 
0 
within a 1 A window. 
D. Summary 
The spermidine linked phenanthridine dimer, BMSpd -- a shortened 
0 0 
tether (1 0 A vs 15 A) analog of BMSp -- was designed to test the relationship 
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of linker length and binding specificity. Like BMSp, BMSpd unwinds DNA 36o 
per bisintercalator suggesting simultaneous intercalation of the two 
phenanthridine chromophores; however, in contrast to the unwinding angie 
determination, the optical titra tions reveal binding affinities and binding site 
sizes character is tic of monointercalation. BMSpd binding constants and 
binding site sizes on sonicated calf thymus DNA in 1 M ( M+) solutions 
and sonicated calf thymus DNA, poly dG·poiy dC, poly dA·po1y dT, and 
poly rA•poly dT in 0.4 M ( M+) solution range from 3.5 x 105 M-1 and 2.5 
base pairs to 6 X 1 o6 M -1 and 4.0 base pairs. It is possible that the 
0 
homopolymer sequences examined are incapable of accommodating a 10 A 
bisintercalation, while BMSpd bisintercalates a small number of as yet 
undefined sites within a heterogeneous sequence and saturates the remainder 
of the "random" sequence with a hanging monointercalator. If this is true, 
BMSpd might be extremely selective in a small number of unpredictable 
cases. 
With regard to the measured binding specificity, however, BMSpd is 
dramatically different from both EB and BMSp. Whereas, EB and BMSp 
prefer rA·dT to dA·dT, BMSpd is ambivalent; rA·dT is bound only 10 times 
more tightly than dA·dT. The nucleic acids that are bound with high affinity 
by EB and BMSp are bound by BMSpd with relatively reduced affinity, and the 
poorly bound homopolymer dA·dT is bound by BMSpd with a relatively 
enhanced affinity. 
What is demonstrated is that linkers cannot only be used to create high 
affinity polyintercalators from monomers building blocks, but that linkers can 
be used to change the specificity 0f a particular intercalator. 
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Part II 
Site Selective Inhibition of Restriction Enzymes 
-39-
A. Introduction 
Simple intercalators efficiently recognize and bind double helical 
nucleic acids. Acridines and phenanthridines exhibit binding constants of 104 
M-1 to 106 M-1,16,39,40 and in some cases these compounds are extremely 
biologically active; however, sequence specific DNA binding proteins binds 
DNA 1 o5 to 1 o7 times more effectively than a simple intercala tor. 6,42 This 
led researchers to seek intercalators with higher binding affinities. The 
answer was to link two monointercalators with a molecular chain to produce 
a polyintercalator .25-27,42 By choosing a sufficiently long linker, the 
affinity of the bisintercalator was buoyed to the affinity of the monomer 
raised to the power of 1.6. 7 
Unexpectedly, the early studies revealed that many of the small 
intercalators bind selectively. A number of the acridine derivatives are base 
specific,39,40,43 while a phenanthridine, ethidium bromide, binds rA·dT 100 
times more tightly than dA·dT.l6 Furthermore, the bisintercalators can be 
even more selective than their constituent monomers. The ethidium dimer, 
bis(methidium)spermine (BMSp), is 14 times more selective than EB itself.? 
The base specificity of a few DNA groove binding molecules and the 
intercalator, actinomycin, has been probed with restriction enzymes. 44-47 
The experiments, in which general inhibition can be distinguished from site 
specific inhibition, showed that different restriction sites are selectively 
inhibited by the base specific intercala tor and the base specific groove 
binders. The selectivity can then be related back to the base specificity of 
the affector and the base sequence surrounding the restriction sites. 
Interestingly, restriction enzymes appear to probe more than just 
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the sequence of the restriction site. Although the recognition sites of a given 
enzyme are identical, the rates of cleavage at each site are not equal, 48 
because the recognition sites are uniquely located with the DNA sequence. 
By monitoring these differential restriction rates can a polyintercalator that 
has been shown to be structure specific with synthetic nucleic acid homo-
polymers and copolymers selectively bind heterogeneous sequences and report 
its locations by inhibiting DNA dependent enzymes directly or indirectly? 
B. Results and Discussion 
Complete cleavage of a covalently closed circular DNA by a specific 
endonuclease produces a unique set of DNA fragments that can be 
characterized by electrophoresis. Although the restriction sites of a given 
enzyme are identical, each site is uniquely located within the heterogeneous 
sequence of the DNA; consequently, the rates of cleavage at each site are 
not equal. The order of cleavage can be determined by observing the 
appearance of partial and final digestion fragments. If a DNA binding 
molecule can site selectively inhibit a restriction enzyme the partial 
digestion patterns may change; conversely, nonselective inhibition of a 
restriction enzyme will only affect the rate of digestion and will not change 
the order of cleavage. Using this logic, the binding of ethidium bromide (EB), 
bis(methidium)spermine (BMSp) and bis(methidium)spermidine (BMSpd), to a 
heterogeneous DNA sequence was probed with a variety of restriction 
enzymes (Fig. 17). 
Initial experiments with EB and BMSp employed predominantly 
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geometrically increasing progression of partial fragments with increasing 
numbers of restriction sites, the restriction enzymes -- Rsa I, Bgl I, and 
Mst I -- were chosen for their limited number of cleavage sites on pBR322. 
The simplicity of the restriction patterns then allows a direct interpretation 
of the changes in relative restriction rates. 
Rsa I, Bgl I and Mst I cut pBR322 at 3, 3, and 4 sites, respectively. 
5'GT Ac3', the recognition sequence of Rsa I, is found at positions 165, 2282, 
and 3847; 5'GCCNNNNNNGGc3', the recognition sequence of Bgl I, is 
located at 934, 1168, and 3487; Mst I's 5'TGCGCA3' is situated at positions 
262, 1357, 1455, and 3589. Complete digestion of pBR322 by Rsa I leads to 3 
final fragments, 2117 bp, 1565 bp, and 680 bp, while Bgl I gives final 
fragments of 234 bp, 2319 bp, and 1809 bp, and Mst I produces 4 restriction 
fragments, 98 bp, 1035 bp, 1095, bp, and 2134 bp. 
At intermediate digestion times partially restricted plasmid fragments 
will appear. Rsa I can produce 3 circularly permuted full length (4362 bp) 
fragments and smaller partial fragments of 3682 bp, 2797 bp, and 2245 bp. 
Likewise, Bgl I can give 3 permuted 4362 bp fragments and partials of 4128 
bp, 2553 bp, and 2043 bp. Finally, Mst I, the most complicated of the three 
enzymes, can create 4 circular permutations of the 4362 bp plasmid, and 8 
partial fragments, 4264 bp, 3327 bp, 3267 bp, 3169 bp, 2232 bp, 2228 bp, 2130 
bp, and 1193 bp. The unperturbed restriction of pBR322 with each of the 
enzymes showed that Rsa I and Bgl I gave all the possible partial and final 
fragments that could be resolved, while Mst I failed to produce at least one 
partial fragment. 
The order of appearance of these partial and final restriction 
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fragments reflects the relative restriction rates at the recognition sites of 
each enzyme. The unperturbed restriction pattern of each enzyme is shown 
in Figure 18. Interpretation of these cleavage patterns of covalently closed 
circular DNA hinges on the fact that the first scission of pBR322 forms a 
4362 bp linear fragment that determines the possible partial fragments that 
may appear. The cleavage sites of an enzyme can then be ranked in order of 
their relative cleavage rates by identifying the bands that appear first. The 
relative restriction rates for the intercalator free digestions are: (1) Rsa I = 
3847 > 165 > 2282; (2) Bgl I = 934 > 116813487, * and (3) Mst I = 
1357 > 1455 > 262 > 3589. A flow chart example of the logic involved is 
presented in Figure 19. 
The addition of EB at 30% saturation ( ( EB) I ( BP) = 0.16) does not 
change the restriction patterns of Rsa I or Bgl I. There is only a reduction in 
the rate of appearance of all the restriction fragments. Conversely, the 
addition of BMSp at 30% saturation ( ( BMSp) I ( BP) = 0.08) changes the 
restriction patterns of Rsa I, Bgl I, and Mst I. Rsa I does not produce a 2245 
bp fragment. Bgl I reverses the order of appearance of the 2553 bp and 2043 
bp partials; the 2043 bp fragment appears before the 2553 bp fragment. 
Finally, Mst I exhibits a totally different restriction pattern. Partial 
fragments of 223212228 bp and 2129 bp now appear in preference to 
fragments of 4264 bp, 3267 bp, and 3169 bp (Figure 18). 
By analyzing the restriction patterns in the manner previously 
described for the intercalator free digestions, the relative order of site 
*A slash punctuating two restriction sites designates :_,sufficient data to 
distinguish the two sites. 
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Figure 18. Restriction Site Inhibition. 
A) Rsa I - Lanes 1-8: Reaction volume = 80 l.li, Total DNA= 
4- l.lg pBR322, enzyme added = 0.5 units, BMSp/DNA (bp) = 0.08, Times (min) = 
1) 4-5, 2)80, 3) 95, 4-) 110, 5) 125, 6) 210, 7) 310, 8) 4-10. Lanes 9-16: 
Intercalator/DNA = 0.00, Times (min) = 9) 140, 10) 100, 11) 75, 12) 60, 13) 4-5, 
14) 30, 15) 15, 16) 10. Electrophoresis = 80 V for 22 h. Gel = 15 x 14-.5 x 0.4-
em. 
B) Rsa I - Lanes 1-8: Reaction volume = 80 lli, Total DNA= 
3 11g pBR322, enzyme added = 0.37 5 units, EB/DNA (bp) = 0.16, Times (min) = 
1) 30, 2) 60, 3) 7 5, 4-) 90, 5) 105, 6) 150, 7) 190, 8) 270. Lanes 9-16: 
Intercalator/DNA = 0.00, Times (min) = 9) 160, 10) 130, 11) 100, 12) 75, 13) 
55, 14-) 4-0, 15) 25, 16) 10. Electrophoresis = 120 V for 12 h. Gel = 15 x 14-.5 x 
0.4- em. 
C) Bgl I - Lanes 1-10: Reaction volume = 50 lli, Total DNA= 
2 llg pBR322, enzyme added = 2.8 units, Lanes 1-5 EB/DNA (bp) = 0.16, Times 
(min) = 1) 2, 2) 5, 3) 10, 4-) 15, 5) 30. Lanes 6-10: Intercalator/DNA = 0.00, 
Times (min) = 6) 1, 7) 3, 8) 6, 9) 9, 10) 15. Lanes 11-16: Reaction volume = 
50 lli, Total DNA = 3 11g pBR322, enzyme added = 4-.2 units, BMSp/DNA 
(bp) = 0.08, Times (min) = 11) 85, 12) 90, 13) 98, 14-) 106, 15) 115, 16) 150. Gel 
electrophoresis= 130 V for 19 h. Gel= 15 x 14.5 x 0.4 em. 
D) Mst I - Lanes 1-6: Reaction volume = 60 lli, Total DNA= 
3.0 11g pBR322, enzyme added = 1.11 units, BMSp/DNA (bp) = 0.08, Times 
(min) = 1) 2, 2) 10, 3) 4-0, 4-) 80, 5) 150, 6) 24-0. Lanes 7-12: Reaction 
volume = 50 lli, Total DNA = 2.4- llg pBR322, enzyme added= 0.89units, 
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Figure 18. Continued 
Intercalator /DNA = 0.00 Times (min) = 7) 540, 8) 300, 9) 270, 1 0) 240, 11) 210, 
12) 180. Gel electrophoresis = 160 V for 41 h. Gel = 30 x 14.5 x 0.4 em. 
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cleavage may be determined for the intercalator doped digestions. Since EB 
does not change the restriction patterns of Rsa I and Bgl I, the analysis of 
these digestion patterns is identical to the intercalator free digestions. 
BMSp, however, alters the restriction patterns of Rsa I, Bgl I, and Mst I. The 
relative cleavage order in the presence of BMSp is now: (1) Rsa I = 
3847 > > 16512282; (2) Bgl I = 116813487 > 934, and (3) Mst I = 3589 > 
1357 I 1455 > 262. The observed perturbations correspond to inhibition at 165 
for Rsa I, 934 for Bgl I and 1357 I 1455 and 262 for Mst I (Table 7). Curiously, 
the span, 165 to 1455, is approximately the number of binding sites that BMSp 
would cover at 30% saturation (Fig. 20). 
Unfortunately, the molecular interpreta~ion of inhibition is obscured 
by the choice of substrate DNA. A topologically constrained molecule adds 
the factor of tertiary structure. Selective inhibition could be a result of (1) 
selective binding of BMSp and direct competition with the enzyme, (2) 
nonselective binding of BMSp and sequence selective alteration of the DNA 
helix to indirectly inhibit restriction activity or (3) alteration of the tertiary 
writhing of the plasmid. As a consequence, to address tertiary structure 
analogous restriction experiments were performed with linear pBR322 DNA 
that was end labeled at the Hind III site with a.-32p nucleotides. With 
this system Rsa I and Bgl I might produce four radioactive fragments: 4331 
bp, 3818 bp, 2253 bp, 136 bp, and 4331 bp, 3458 bp, 1139 bp, 905 bp, 
respectively, while Mst I could show five fragments 4331 bp, 3560 bp, 1426 
bp, 1328 bp, and 233 bp. 
Interpretation of the linear restriction patterns is much simpler than 
the interpretation of the supercoiled restriction patterns. In the linear 
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§ ~ 
Enzyme Site EB at BMSp Site EB at BMSp BMS8d Order 0 .16 at 0.08 Order 0. 16 at 0.08 at 0. 8 
3847 3847 3847 3847 3847 3847 3847 
Rsa I > 165 > 165 >> 165 I 165 I 165 > 165 > 165 
> 2282 > 2282 I 2282 > 228~ > 2282 .._ 2282 I 2282 
934 934 1168 934 934 934 934 
Bgl I > 1168 > 1168 I 1387 > 1168 > 1168 .._ 1168 .._ 1168 
I 3487 I 3487 > 934 > 3487 > 3487 ---3487 ---3487 
1357 3589 262 3589 
> 1455 > 1357 > 1357 > 1357 
Mst I > 262 I 1455 > 1453 '"'- 2 62 
> 3589 > 262 > 3589 > 1453 
Enzyme 
EB BMSp EB BMSp BMSpd 
Inhibition Inhibt tion Inhibition Inhibition Inhibition 
Rsa I NSI 165 NSI 165 165 
Bgl I NSI 934 NSI 
934 934 
> 1168 > 1168 
1357 1455 
Mst I 1455 > 262 
> 1357 










2000 3000 4361/0 
pBR322 Eco RI 
Figure 20 
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Figure 21. Rsa I 
Control - Lanes 1-6: DNA = 2.5 llg, Rsa I= 0.5 un., No Interca1ator, 
Times (min) = 0.5, 1.5, 3, 5, 9, 17 - from lane 1 to lane 6. 
EtBr - Lanes 7-12: DNA = 2.5 llg, Rsa I= 0.5 un, EtBr/DNA = 0.16, 
Times (min) = 1, 2, 4-, 6, 12, 22 - from lane 7 to lane 12. 
BMSp - Lanes 13-18: DNA = 2.5 llg, Rsa I = 0.5 un, BMSp/DNA = 0.08, 
Times (min)= 1, 3, 7, 15, 25, 4-5- from lane 13 to lane 18. 
BMSpd - Lanes 19-24-: DNA = 2.5 llg, Rsa I= 0.5 un, BMSpd/DNA = 




2 3 4 5 6 
BMSp 
EtBr 
7 8 9 10 II 12 
BMSpd 
13 14 15 16 17 18 19 20 21 22 23 24 
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Figure 22. Bgl I 
Control - Lanes 1-6: DNA = 2.5 llg, Bgl I = 1.5 un., No Intercalator, 
Times (min) = 1, 2, 4, 7, 15, 25 - from lane 1 to lane 6. 
EtBr - Lanes 7-12: DNA = llg, Bgl I= 1.5 un., EtBr/DNA = 0.16, Times 
(min) = 2, 3, 5, 8, 15, 25 - from lane 7 to lane 12. 
BMSp - Lanes 13-18: DNA = 2.5 llg, Bgl I= 1.5 un., BMSp/DNA = 
0.08, Times (min) = 10, 30, 60, 90, 130, 180 - from lane 13 to lane 18. 
BMSpd - Lanes 19-23: DNA = 2.5 llg, Bgl I = 1.5 un., BMSpd/DNA = 




2 3 4 5 6 7 8 9 10 II t2 
BMSp BMSpd 
13 14 15 16 17 18 19 20 21 22 23 
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Figure 23. Mst I 
Control- Lanes 1-5: DNA= 2.3 llg,Msti=l.Oun.,Nointercalator, 
Times (min) = 15, 20, 30, 45, 65 - from lane 1 to lane 5. 
BMSp - Lanes 6-10: DNA = 2.3 llg, Mst I = 1.0 un., BMSp/DNA = 
0.08, Times (min) = 45, 65, 90, 120, 165 - from lane 6 to lane 10. 
Top set of lanes was electrophoresed for 24 h at 100 volts, whiie the 
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restrictions the order of appearance of the DNA fragments is exactly the 
order of site cleavage; however, the nature of the assay makes it more 
difficult to detect perturbations in cleavage rates. For example, specific 
inhibition would be seen as changes in the relative rates of appearance of 
specific fragments with respect to the fragment that appears most slowly. 
Restrictions in intercalator free solutions show that Rsa I, Bgl I, and 
Mst I give all the resolvable restriction fragments. The order of appearance 
of these fragments (Figs. 21, 22 and 23) yields cleavage rankings of 
3847 I 164 > 2282 for Rsa I, 934 > 1168 > 3487 for Bgl I, and 262 > 
1357 > 1455 > 3589 for Mst I (Table 7). 
Again, EB at 30% saturation induces no changes in the restriction 
patterns of Rsa I and Bgl I. There is only a general inhibition of all sites; no 
specific inhibition is apparent. The antithesis is once more BMSp. Even with 
linear pBR322, BMSp at 30% saturation (( BMSp) /( BP) = 0.08) changes the 
restriction patterns of Rsa I, Bgl I, and Mst I. In the case of Rsa I, the 
appearance of the 136 bp fragment is slowed in relation to the appearance of 
the 2253 bp fragment. For Bgl I, the 905 bp fragment and the 1139 bp 
fragment appear in conjunction with the 3458 bp fragment instead of 
appearing ahead of the larger fragment. In addition, the two small fragment 
appear simultaneously; whereas the control digestion shows the 905 bp 
fragment appearing before the 1139 bp fragment. Finally, the Mst I 233 bp 
fragment and 1328 bp fragment are slow to appear in relation to the 3560 bp 
fragment, while the 2426 bp fragment is almost eliminated (Figs. 21 and 22). 
These BMSp doped restriction patterns correspond to the cleavage 
orders (1) Rsa I = 3847 > 165 - 2282, (2) Bgl I = 934 - 1168 - 3487, 
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and (3) Mst I = 3589 > 1357 - 262 > 1455 which are different from the 
restriction orders of the intercalator free digestions. The changes induced by 
BMSp indicate specific inhibition at the same sites identified with the 
supercoiled substrate, Rsa I = 165, Bgl I = 934, and Mst I = 1455. 
Furthermore, it was possible to deduce that the sites at Bgl I = 1168, Mst I = 
262, and Mst I = 1357 were also inhibited in the presence of BMSp (Table 7). 
Apparently, tertiary structure does not affect the restriction inhibition 
induced by a bisintercalator. 
Since the two assays lead to the same conclusions a newly synthesized 
dimer, bis(methidium)spermidine (BMSpd), was added to the linear substrate 
assays. BMSpd differs from BMSp in the length of the linker tethering the 
0 
chromophores. The spermine tether stretches to a length of 15 A, while the 
0 
spermidine tether only spans 10 A. Biophysical measurements suggest that 
BMSpd may act like a dimer at very low saturations and resemble a monomer 
at high saturations. Consequently, it was not surprising to find that BMSpd at 
30% saturation ( ( BMSpd) I ( BP) = 0.08) is not as effective as BMSp, but does 
inhibit the same sites as the spermine dimer (Figs. 21 and 22, Table 7). 
Having ascertained that methidium dimers inhibit restriction sites in 
the first third of the pBR322 plasmid, the restriction enzyme Taq I was 
chosen for a more detailed mapping of the inhibition induced by the two 
bisintercalators. With this system only the five smallest fragments were 
monitored and the data were interpreted as previously described. It was found 
that site selective inhibition by BMSp is saturation dependent. The number of 
Taq I sites inhibited decreases with decreasing concentrations of BMSp. At 
0.03 molecules of BMSp per base pair of DNA only the Taq I site at 339 is 
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specifically inhibited. Moreover, EB again induces no selective inhibition, 
whiie BMSpd distinguishes itself from BMSp. At a saturation of 0.03 
molecules of BMSpd per base pair of DNA, BMSpd inhibits three sites in the 
order 339 > 1126 > 651 (Table 8, Fig. 24). It might be that BMSpd is acting at 
two sites near positions 339 and 1126, while BMSp only sees the site at 339, 
or it is possible that BMSpd is simply less selective than BMSp. 
To substantiate that the intercalators were acting on the DNA and not 
on the enzymes, a series of DNase protection experiments were attempted. 
In these studies DNase I was substituted for the restriction enzymes. If the 
first third of the pBR322 plasmid can be protected from DNase cleavage by 
the intercalators, a persistent "smear" should appear during the digestion of 
the linear plasmid. DNase nicking of pBR322 end labeled at the Hind III 
restriction site showed that an intercalator free digest was quickly and 
progressively reduced to small fragments. The same digestion pattern was 
observable in the presence of EB at 30% saturation; however, BMSp and 
BMSpd at 30% saturation cause the persistence of a smear between 500 bp 
and 1000 bp (Fig. 25). The opposite end label at Eco RI gives no smeared 
band as expected. 
Direct physical corroboration of the relationship between restriction 
site inhibition and intercalator binding was addressed. A covalently binding 
analog of bis(methidium)spermine was designed and synthesized. The 
strategy was to radio label the bisinterca1ator, bis(monoazidomethidium)-
spermine (BAMS) (Fig. 26), covalently bind BAMS to its equilibrium binding 
sites, and determine the location of the bound interca1ator. It was found that 
the high specific activity required, and the la~k of a dedicated radiosynthesis 
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Figure 24. Taq I 
Control - Lanes 1-5: DNA = 1.5 1Jg, Taq I= 0.5 un., No Intercalator, 
Times (min) = 0.5, 1, 2, 4, 8 - from lane 1 to lane 5. 
BMSp 0.06 - Lanes 6-10: DNA = 1.5 1Jg, Taqi=0.5un.,BMSp/DNA= 
0.06, Times (min) = 2, 4, 8, 16, 32 - from lane 6 to lane 10. 
BMSp 0.03 - Lanes 11-15: DNA = 1.5 lJg, Taq I = 0.5 un., BMSp/DNA = 
0.03, Times (min) = 1, 2, 4, 8, 16 - from lane 11 to lane 15. 
BMSp 0.08 - Lanes 16-20: DNA = 2.5 1Jg, Taq I = 2.0 un., BMSp/DNA = 
0.08, Times (min) = 45, 65, 90, 120, 165 - from lane 16 to lane 20. 
EtBr 0.06 - Lanes 21-25: DNA = 3.0 1Jg,Taqi=3.0u.1.,EtBr/DNA= 
0.06, Times (min) = 2, 4, 8, 16, 32 - from lane 21 to lane 25. 
BMSpd 0.03 - Lanes 26-30: DNA = 3.0 llg, Taq I = 3.0 un., 
BMSpd/DNA = 0.03, Times (min) = 3, 6, 12, 24, 48- from lane 26 to lane 30. 
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Taq I 
Control BMSp 0.06 BMSp 0 .03 
I 2 3 4 5 6 7 8 9 10 II 12 13 14 15 
BMSp 0.08 EtBr 0 .06 BMSpd 0.03 
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
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Figure 25. DNase I 
Control - Lanes 1-5: DNA = 1.5 llg, DNase = 20 ng/mL, No Inter-
calator, Times (min) = 1, 3, 6, 12, 24 - from lane 1 to lane 5. 
EtBr - Lanes 6-10: DNA = 1.5 llg, DNase = 20 ng/mL, EtBr/DNA = 
0.16, Times (min) = 1, 3, 6, 12, 24 - from lane 6 to lane 10. 
BMSp - Lanes 11-15: DNA = 1.5 llg,DNase=20ng/mL,BMSp/DNA= 
0.08, Times (min) = 1, 3, 6, 12, 24 - from lane 11 to lane 15. 
BMSpd - Lanes 16-20: DNA = 1.5 11g, DNase = 20 ng/mL, 
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facility made the tritium labeled synthesis of BAMS too hazardous to be 
viable at Caltech (Fig. 27). The synthesis could even be unfit for radioisotope 
laboratories unless provisions were made for dark room illumination to 
protect the azide functionality of BAMS. 
C. Summary 
The bisintercalators, BMSp and BMSpd, can selectively inhibit 
restriction sites in a heterogeneous sequence of pBR322 DNA and can protect 
this same region from DNase cleavage. With pBR322, BMSp and BMSpd at 
30% saturation inhibit DNA cleavage over the first third of the plasmid. 
Furthermore, the number of sites protected is proportional to the concentra-
tion of the bisintercaiator. The greatest selectivity is observed with BMSp at 
low saturations. In this case, inhibition seems to predominate in the region of 
the Taq I-339 restriction site. Conversely, EB shows no selective inhibition. 
Why EB is not selective appears to be a consequence of both the low binding 
affinity of the monomers and the lack of other dimeric properties. 
The molecular interpretation of the restriction inhibition by BMSp and 
BMSpd is a little more obscure. The "clustering" of inhibited restriction sites 
suggests a cooperative phenomenon. The bisintercalators may bind and 
physically protect the bound DNA, or they may induce a cooperative 
perturbation of the DNA secondary structure in the region of the inhibited 
restriction sites. In either case, tertiary structure is apparently not 
important. What may determine the region of inhibition is the nature of the 
primary sequence. Since methidium analogs are not base specific, and 
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secondary structure is not intimateiy specified by the identity of the bases, 
the selectivity would not be determined by the primary identity of the bases, 
but by the overall structure and conformational lability of the sequence. In 
short, selective DNA cleavage inhibition by BMSp and BMSpd might be a 
consequence of the recognition of DNA conformation by the intercalators, or 
the DNA dependent enzymes or both the intercaiators and the enzymes. 
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Materials and Methods 
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Part I 
Synthesis of Bis(methidium)spermidine Hydrochloride. A dry 200 mL, 
three-necked round-bottom flask was equipped with an argon inlet tube, a 
septum, and a stopper. A magnetic stirrer was placed in the flask, and the 
flask was flushed with argon for 1 min. 1.53 g of recrystallized paracarboxyl 
methidium chloride (PMCl, 100 mol %)1 was placed in the flask, and the flask 
was sealed. 50 mL of dry dimethyl sulfoxide (Baker Analyzed reagent, 
DMSO) and 0.40 mL dry N-ethyl morpholine (Eastman Practical) were then 
syringed onto the PMCI, and the mixture was stirred till dissolution. 765 mg 
of freshly sublimed 1 ,1-dicarbonyl diimadazole (117 mol %, Aldrich, 98%) in 
8.8 mL of dry DMSO were then syringed into the PMCl solution, and the 
mixture was allowed to stir. An hour after the addition of the dicarbonyl 
diimadazole, 285 mg of dry spermidine (97 mol %, Aldrich, 98%) in 2.85 mL 
of dry DMSO was added to the reaction mixture, and the reaction was 
followed by TLC (cellulose plates developed in 50/50 mixture of 0.025 M, pH 
7, phosphate buffer, isopropanol). After 48 h of stirring the solvents were 
evaporated, and a purple solid was recovered. 
Purification of BMSpd. During the synthetic reaction 7 50 g of silica 
gel 60 (EM reagents, 70-230 mesh) were prepared by repeatedly washing the 
material with eluent. The eluent consisted of dry methanol (Baker analyzed, 
low acetone) acidified with acetyl chloride (Mallinkrodt AR, bp, 49-53°C) at 
a level of 7 mL of acetyl chloride per 1000 mL methanol. A column was 
filled with the purified silica gel, and the column was pre-eluted with the 
methanol eluent. Approximately half the solids coHected from the synthetic 
reaction were dissolved in 150 mL of a-:idic methanol and applied to the 
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column. The BMSpd fraction was collected, concentrated, and rechromatog-
raphed on fresh silica gel. This time, the BMSpd was concentrated and 
filtered through a fine glass frit and afterward evaporated to dryness. The 
solids were taken up in a minimum volume of 1 N HCl, and tetrahydrofuran 
was added to the solution to induce reprecipitation of the compound. The 
solids were collected, washed with THF, and dried at 1 oooc under reduced 
pressure. This yielded 290 mg of BMSpd contaminated with 3-5% 
uncombustible material. 
Final purification of the BMSpd was accomplished by chromatography 
on Bio-Rad 70, hydrogen form, cation exchange resin (1 00-200 mesh). This 
was done by dissolving 19 mg of the 97% BMSpd in 15 mL of doubly distilled 
water. The solution was then applied to an 11 em column of the cation 
exchange resin, and the column and BMSpd were washed with a liter of doubly 
distilled water. The BMSpd was then washed with 150 mL dry methanol and 
lastly, eluted with acidic methanol. The BMSpd fractions were collected, and 
the solution was evaporated to dryness. The BMSpd was then "recrystallized" 
out of 1 N HCl/THF and dried. 10 mg of analytically pure BMSpd were 
recovered. The overall yield was impossible to calculate since the reaction 
solids were split before the first chomatography. IR (KBr): Figure 28. 
UV /VIS: maxima = 214, 288, 501 nm ( s = 8835, 0.025 M, pH 7, phosphate 
buffer). 1H NMR (D6-DMS): Figure 29; 13c NMR (D6-DMSO): Figure 30. 
Elemental Analysis: BMSpd·4 H20. Found: C, 59.82; H, 5.91, N, 
12.94; Cl, 10.94. Calculated: C, 60.18; H, 6.18; N, 12.95; Cl, 10.88. 
Buffers. All buffers are referred to by their total concentration of 
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sodium chloride to a phosphate buffer containing 0.028 M Na2P04 and 0.019 
M KHP04: (1) ( M+) = 0.075 M, no NaCl added; (2) ( M+) = 0.4 
M, (NaCl) = 0.31 M and; (3) (M+) = 1.0 M, (NaCl) =0.9M. ThepH 
of the solution was then adjusted to pH 7 with 1 M NaOH. 
Calf thymus DNA: Highly polymerized calf thymus DNA was cleaned 
by extraction with phenol and ether. It was then sonicated at ooc under 
argon 16 and fractionated on sepharose 4B. The fractions collected yielded 
double stranded DNA approximately 300 base pairs in length. 
Synthetic polymers. Poly dA·poly dT, poly rA·poly dT, and 
poly dG·poly dC were obtained from P-L Biochemicals. Each was rehydrated 
and twice dialyzed against 0.4 M ( M+), pH 7, phosphate buffer. In addition, 
it was necessary to sonicate the poly dG·dC sample. Sonication and 
fractionation as previously described followed by pH annealing37 yielded 
double stranded poly dG·dC approximately 500 base pairs long. The polymer 
solutions were then sterilized by filtration through an 0.45 11m millipore 
filter. 
PM2 DNA. Covalently closed circular PM2 DNA was obtained from 
Boehringer Mannheim Biochemicals. 
DNA Concentrations. All DNA concentrations were obtained spectro-
photometrically assuming the following extinction coefficients: calf thymus 
and PM2 - 6600 nuc-1 cm-1 at 260 nm; poly dA·poly dT - 6000 nuc-1 cm-1 
at 258 nm; and poly dG·poly dC- 7400 nuc-1 cm-1 at 255 nm. 
Unwind Angle Determination. 50 11L of a 50 mM Tris/HCl (Sigma, 
reagent grade tr is(hydroxymethyl) amino methane/tr is(hydroxymethyl)amino 
methane hydrochloride) pH 7 .8, 10 mM MgCl2 (Baker, analyzed reagent, 
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99.5%) and 2 mM dithiothreitol (Calbiochem, 99%) buffer were measured into 
six bullet vials. 2 1-1g of closed circular PM2 DNA, 4 units of superhelical 
relaxing enzyme (BRL-purified from Agrobacterium tumefaciens strain 
10 135), and a progressively increasing amount of intercala tor were added to 
each vial. The mixtures were incubated for 12 h at 370C. Four units more 
superhelical relaxing enzyme were added and the reaction mixtures were 
incubated an additional 12 h. At the end of the incubation 10 1-1L of 
10% sodium dodecyl sulfate (MC/B) were added to denature the enzyme, and 
30 1-1g tRNA were added as carrier. The samples were phenol extracted and 
the intercalator was removed by chromatography on a microcolumn of cation 
exchange resin (Biorad AG50W-X8, Tris form). The DNA was recovered from 
the columns in 2-200 1-1L aliquots of 1 M sodium acetate (Mallinkrodt, AR) 1 
mL isopropanol (Baker, analyzed reagent) was added and the alcoholic 
solution was frozen. The DNA was then pelleted by centrifugation at 15,000 
rpm for 8 min. The pellet was washed with ethanol and reprecipitated. The 
washing was repeated, and the pellet was dried under vacuum. The 
dessicated DNA was then dissolved in 80 1-1L loading solution, 5% ficoll 
(Sigma, type 400), 0.025% bromophenol blue (Sigma), 0.025% xylene cyanol, 
and 1 mM ethylenediamine tetraacetic acid (Baker, analyzed reagent, 99.7%). 
Approximately 400 ng of DNA from each sample were loaded onto a 15 em x 
14 em x 0.4 em, 1% agarose (Sigma, electrophoretically pure) gel (buffer: 40 
mM Tris/HCl, pH 7 .8, 5 mM sodium acetate, 1 mM EDTA, and 
1-25 1-1g/mL chloroquine -- a concentration appropriate to resolve the super-
helical bands). The electrophoresis was allowed to run for 20 h at 70 volts 
and 60 milliamps. Electrophoresis buffers were circulated by peristaltic pump 
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and were replaced after 10 h of the electrophoresis. Upon completion of the 
electrophoresis, the gel was stained in 2 11g/mL ethidium bromide (Sigma) 
for up to 6 h and destained for 12 to 24 h. The gel was then recorded by 
photography under ultraviolet transillumination, and the unwinding angle was 
determined from the s,hift of the superhelical PM2 bands. 
Spectrophotometric Titrations. Optical titra tions were performed on 
a Cary 219 utilizing fixed block sample stages and 10 em cells. Ambient 
temperature was controlled at 22oc ~ 1 oc to provide machine stability and 
thermodynamic constancy. The 10 em cells were filled dust free with 25 mL 
of millipore filtered buffer, and clean DNA was syringed into the cells. 
Increasing amounts of BMSpd were added to the nucleic acid solution, and the 
absorbance was recorded for each addition of BMSpd. After the mixtures 
0 
attained equilibrium, absorbances were reproducible to ~0.0002 A. 
Bound Spectra. The spectrum of BMSpd bound to a nucleic acid was 
determined by recording the spectrum of BMSpd in the presence of a high 
concentration of the appropriate DNA ((DNA) - 100/estimated BMSpd 
binding constant). Approximately, ten separate spectra were recorded at ten 
different ratios of intercalator to DNA. The bound spectrum of BMSpd was 
then extracted from the data by the methods of Bontemps and Fredericq.38 
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Part ll 
Enzymes. Rsa I, Bgl I, Mst I, Taq I, Eco RI, Hind III, large fragment 
DNA polymerase, and DNase I were purchased commercial. 
Nucleic Acid. 49 Plasmid pBR322 was used as substrate DNA for the 
entire study. A portion of the pBR322 was purchased commercially. The 
remainder of the pBR322 was isolated from transformed E. Coli HB101 after 
amplification of the plasmid with chloramphenicol. The superhelical DNA 
was then purified by equilibrium sedimentation. 
Concentrations were determined spectrophotometr ically assuming an 
extinction coefficient at 260 nm of 6600 (M nuc)-1 cm-1. 
Intercalators. Ethidium bromide was obtained commercially, while 
bis(methidium)spermine 1 and bis(methidium)spermidine were synthesized. 
Intercalator concentrations were determined spectrophotometrically. 
Extinction coefficients - EB = 5700 M -1 cm-1 at 480 nm in pH 7, 0.07 5 M 
phosphate buffer;1 BMSp = 9850 M-1 cm-1 at 501 nm in pH 7,1, 0.075 M 
phosphate buffer; and BMSpd = 8835 M-1 cm-1 at 501 nm in pH 7, 0.075 M 
phosphate buffer. 
End Labeling. 49 Plasmid pBR322 cut with Hind III or Eco RI was 
labeled with an appropriate nucleoside 5'-( a-32p) triphosphate and large 
fragment DNA polymerase. Recutting the products of the labeling reaction 
with Eco RI or Hind III yields an almost full length linear fragment labeled at 
one end. 
Digestion Conditions. The amount of DNA (pBR322: 2-4 micrograms), 
the volume of the reaction buffer (60-1 00 microliters, 50 m M Tr is/HCl - pH 

































albumin) and the amount of enzyme (0.5 to 2 units for restriction enzymes 
and 1.25 ng/mL DNase I) were set so that the relative concentrations of DNA 
and enzyme would remain near constant for the assays done with one enzyme 
and so that samples could be withdrawn from the reaction mixture at 
reasonable intervals over the entire digestion period. Since the method 
revolves about the relative kinetics of the restrictions, the digestion samples 
were mixed with the intercalator in the absence of the enzyme, and the 
system was allowed to equilibrate for 1 h. The samples were then brought to 
37oc over 15 min, and the enzyme was added at time 0. Each sample was 
stopped with 5 to 15 microliters of 5% sodium dodecyl sulfate and was stored 
frozen until the sample could be purified. 
Samples were extracted with phenol, washed with ether, and prepared 
for loading onto the gel. For gels where resolution was critical, the samples 
containing BMSp or BMSpd required an extra purification step, since either 
bisintercalator can seriously affect the mobility of DNA through a gel. 
After phenol extraction of the dimer samples, each applied to a 
BioRad cation exchange (AG50W -X8, 100-200 mesh) column, and the DNA 
was eluted with 1 M sodium acetate. The DNA was then precipitated and 
prepared for loading onto the gel. Control experiments confirm that the 
cation exchange columns do not selectively remove any restriction 
fragments. 
Electrophoresis. 49 The DNA samples cleaved by restriction enzymes 
were loaded onto 15 x 14 x 0.4 em or 30 x 14 x 0.4 em vertical gels of 5% 
polyacrylamide. The gels were then run in tris/borate buffer (90 mM 
Tris/borate - pH 8.3, 2.5 mM EDT A) fol an appropriate period, and after-
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wards the gels were visualized by either autoradiography or ethidium bromide 
staining and UV transillumination. 
The DNase I digested samples were run on 15 x 14 x 0.1 em 5% 
acrylamide, urea denaturing gels as described for the restricted samples. The 
gels were then visualized by autoradiography. 
Synthesis 
Bis(monoazidomethldium)Spermine. The following synthesis was 
performed under dark room conditions. Illumination was provided by a single 
safety lamp fitted with a Kodak Safelight Filter No. 2. A dry single neck 50 
mL round-bottom flask was flushed with argon. A magnetic stirring bar, 212 
mgs of para-carboxy(monoazidomethidium) chloride (PCAM),50 and 20 mL 
dry dimethyl sulfoxide (DMSO) were placed in the flask, and the flask was 
sealed with a septum stopper. 85 mg 1 ,!-carbonyl diimidazole (Aldrich, mp 
118-1200C, 105 mol%) were dissolved in 2 mL dry DMSO. This 2 mL solution 
was .syringed into the reaction flask and the reaction was allowed to stir for 1 
hour. 50 mg of spermine (Aldrich, 97% - 49 mol %) in 0.5 mL dry DMSO was 
then syringed into the reaction. The solution was allowed to stir for 48 h. 
A hundred microliters of water were added to the reaction, and after a 
half hour the DMSO and water were evaporated at 600C and 1 mm pressure. 
The solids were then dissolved in 100 mL methanol. 
Silica gel 60, 70-230 mesh, was prepared by repeatedly washing the 
silica with dry methanol acidified with 4 mL of fresh acetyl chloride per 1000 
mL of methanol. A column was filled with 650 g of the purified silica gel, 
ard the column was pre-eluted with the acidic methanol. The methanolic 
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solution of the reaction mixture was then applied to the column and eluted 
with acidic methanol. The fractions containing the bis(monoazidomethidium) 
spermine were collected and concentrated. The concentrated sample was 
filtered through a fine glass frit, and afterwards the solution was evaporated 
to dryness. The solid BAMS was redissolved in a minimum volume of 1 N 
HC1, and the products were reprecipitated with tetrahydrofuran. The oily 
BAMS was collected by centrifugation and dried under reduced pressure. 
Overall, the synthesis yielded 100 mg of purified BAMS. IR (KBr): Figure 31; 
NMR (D6-DMSO): 0 9.0-7.3 and 6.3 (m, 20H, aromatic), 3.98 (m, 6H, CH3), 
3.5 (m> 6H, NH and H20), 3.10 and 1.77 (m, 20H, CH2). Secondary Ion Mass 
Spectroscopy: m/z = 879 (-N2) and m/z = 850 (-2 N2). 
1,12-Diamino-4,9-diazodecyne-6.51 The hood and reaction flask were 
covered with aluminum foil to protect the light sensitive starting material, 
1 ,4-dichlorobutyne-2. A 100 mL, 3-neck round-bottom flask equipped with an 
argon inlet and sealed with two septum stoppers was filled with 50 mL of 1,3-
diaminopropane (Aldrich, 9896). While the diamine was magnetically stirred, 
6.1 g of 1 ,4-dichlorobutyne-2 (Aldrich, 9996) was added in increments of 0.2 
m L over 12 h. The reaction was then allowed to stir an additional 12 h before 
11 mL of 10 M KOH were added to the mixture. The precipitated salts were 
filtered out of the reaction, and the low boiling compounds were distilled 
from the product 1 ,12-diamino-4,9-diazadecyne-6. The product was 
redissolved in CH2Cl2, and the solution was filtered. The CH2Cl2 was 
evaporated and the viscous oil was Kugelroh~· distilled. This yield 4.8 g of 
analytically pure 1, 12-diamino-4,9-diazadecyne-6. IR (neat): Figure 32; 
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1.1 (s, 6H, NH and HN2); 13c NMR (CC14) 8 (TMS =0ppm),33.20,38.21, 
40.29, 46.34, 81.36 ppm. 
Elemental analysis calcd. for C 1 oH22N4: C, 60.57; H, 11.18; N, 
28.25. Found: C, 60.53; H, 10.9 5; N, 28.06. 
( Tetramethylene-2,3-3H) Spermine.51 The following procedure was 
devised using H2· The procedure and the polyamino-alkyne was then sent to 
New England Nuclear for conversion of the 1 ,12-diamino-4,9-diazadecyne-6 
into tritium labeled spermine, ( Tetramethylene-2,3-3H) spermine. 200 mg 
of starting material yielded 4 Ci of 3H activity. 
104 mg of 1 ,12-diamino-4,9-diazadecyne-6 was dissolved in 0.8 mL of 
dry ethanol. 40 microliters of glacial acetic was added to the ethanol and, 
the solution was transferred to a microhydrogenator. The reaction mixture 
was degassed, and 30 mg 10% Pd/C were added to the mixture. The reaction 
was placed under 10 lbs (gauge) of H2 and hydrogenated for 24 h. 
After the hydrogenation was completed, the catalyst was filtered off 
the reaction and an excess of HCl was added to the ethanol. The reaction 
solvent was evaporated, and the salts were redissolved in distilled water. 
NaOH was added to the aqueous solution of spermine, and the water was 
evaporated. The solids were then triturated with CH2Cl2, and the CH2Cl2 
was cleared of solids. Evaporation of the CH2Cl2 yielded 65 mg of spermine 
(62%). NMR (CDC13) 8 2.6 (m, 12H, CH2), 1.5 (m, 8H, CH2), 1.3 (s, 6H, NH 
and HN2). 
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CHAPTER ll 
Experiments in the Design of Site Specific 
DNA Cleaving Agents 
-92-
A. Introduction 
It was recognized that the specificity and affinity of an 
intercalator 1-7 might be useful in delivering chemical functionality and/or 
chemical activity to the nucleic acid double helix, 18 the general strategy 
being the design of a synthetic route to piggyback a chemically reactive unit 
on a vehicle with nucleic acid destinations.l8 
The natural product bleomycin, has a chemically reactive unit 
tethered to a DNA specific vehicle. Bleomycin consists of a glycosylated 
pseudotetrapeptide that is capable of chelating a metal ion, and of tripeptide 
S vehicle that is thought to bind DNA at guanine residues8-l 0 (Fig. 1). 
In the presence of Fe(II) and 02, bleomycin can mediate an efficient 
cleavage of DNA at 5'Gc3' and 5'GT3' sites.ll-13 The oxygen dependent 
strand scission yields a 5' phosphate, a 3' glycolate, and a base propenal. In 
the absence of oxygen Fe(II)-bleomycin attack yields free base and base labile 
apyrimidinic sites 14--17 (Fig. 2). It is hypothesized that the antitumor 
properties of bleomycin may be due in part to the unrepairable double 
stranded cleavage of "host" DNA induced by activated bleomycin. 
With bleomycin as a model, Hertzberg and Dervan designed a molecule 
to deliver a chemically reactive unit to the DNA double helix. The molecule 
synthesized, methidiumpropyl-EDTA (MPE) consists of a metal chelator, 
ethylenediamine tetraacetic acid, tethered by a diaminopropane linker to a 
nucleic acid intercalator, paracarboxylmethidium chloride (Fig. 3).18 Like 
bleomycin, MPE cleaves DNA in the presence of Fe(II) and 02, however, MPE 
is less efficient than bleomycin. A reducible co-factor (dithiothreitol-DTT) 
must be added to MPE reactions to obtain activity comparable to the natural 
HzNOC h CH, 0 
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Unlike bleomycin, MPE cleaves DNA randomly; it reflects the 
nonspecific intercalation of methidium.l9-21 As a nonspecific DNA cleaving 
agent, MPE may be considered the synthetic equivalent of DNase. 
Although MPE like bleomycin uses Fe(II) as a co-factor for the 
cleavage of DNA, the mechanisms of the two compounds must diverge. In 
contrast to bleomycin, MPE•Fe(II) reactions exhibit a stoichiometric relation-
ship of free base to strand scission, and a mixture of products at the 3' 
cleavage termini.24 These characteristics are similar to the damage induced 
by X-ray irradiation of nucleic acid and suggest that the active intermediate 
in MPE·Fe(II) reactions is hydroxyl radical (Fig. 4). 
Whatever else future experiments might intimate about the 
mechanism of MPE·Fe(II) cleavage they will not refute the observation that a 
properly delivered EDT A·Fe(II) can efficiently mediate the single strand 
cleavage of DNA. Having demonstrated that it is possible to piggyback a 
chemically reactive molecule on a DNA binding vehicle, the logical 
extension of this line of reasoning calls for the synthesis of a site selective 
cleaving agent. 
The naturally occurring antibiotic distamycin25,26 is known to 
preferentially bind in the minor groove of A-T double helices. The amide 
hydrogens of these polypyrrole molecules recognize A-T base pairs 
by hydrogen bonding to the 0(2) of thymine or the N(3) of adenine27-30 (Fig. 
5). Schultz and Dervan recognized that an EDT A could be easily appended to 
either end of the distamycin tripyrrole and hoped that the EDT A would be 
selectively delivered to sequences specifically rec~gnized by the distamycin 
0 
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analog; subsequently, distamycin-EDT A (DE) and EDT A-distamyciri (ED) 
were synthesized (Fig. 6).31 ,32 
Analysis of the cleavage patterns of these two molecules revealed 
single strand scission at pentanucleotide recognition sites containing at least 
h d . h h . . 5'AAATT3' and 3'AATAA3'. t ree a en1nes or t ree t ym1nes, 1.e., 
Interestingly, nicking occurs at both ends of the recognition site, but with a 
consistent directional inequality; one end of the recognition site is 
preferentially cleaved. Since the directional inequality of DE and ED 
cleavage point in opposite directions, the tripyrrole must bind with a specific 
directional preference that the tethered EDT A does not significantly 
perturb.32 Such information is an example of the advantages of affinity 
cleavage over footprinting in determining the binding characteristics of a 
small · molecule. 
The success of DE and ED lead to the synthesis of three new cleaving 
agents, penta-N-methylpyrrolecarboxamide-EDT A (P 5E),33 bis(EDT A-dista-
mycin) (BED),34 and EDT A-(bisdistamycin) (EBD).34 The construction of 
these molecules was again based on the polypyrrole subunit of distamycin, but 
in this case the molecules were designed to recognize sequences longer than 5 
base pairs (Fig. 7). Experimental analysis revealed that P5E·Fe(II) cleaves 
adjacent to sequences of six adenines and thymines (i.e., 5'TTTTT A3'),33 
while BED·Fe(II) and EBD·Fe(II) fragment the DNA helix beside sequences of 
eight adenines and thymines (i.e., 5'TTTTT AT A3').34 Surprisingly, all three 
molecules were shown to cleave both strands of the DNA helix.33,34 In 
short, P5E·Fe(II), BED·Fe(II) and EBD·Fe(II) can bind a specific recognition 
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one of these three reagents produces discrete fragments on a nondenaturing 
electrophoretic gel. 
What began as a simple exercise in delivered chemical functionality 
has now evolved into the design of site specific DNA cleaving agents. 
Although P5E·Fe(II), BED·Fe(II), and EBD·Fe(II) are primitive, first generation 
molecules, their specificity and activity suggest that an efficient cleaving 
system may eventually become useful. In the interim, a problem that must 
be confronted is the design of specificity. How can a molecule be sculptured 
to recognize a defined sequence of any length? 
It is well known that a small single stranded oligonucleotide will 
anneal to its complement to form a double helix. The renaturation reaction 
is highly specific and allows an oligonucleotide to locate a homologous 
sequence among a large excess of random sequences. If an EDT A·Fe(II) could 
be appended to a single stranded fragment of DNA, the cleaving agent could 
be delivered to any sequence of choice. As a consequence it might be 
possible to cleave DNA at experimentally convenient sites instead of at the 
limited number of recognition sites for known restriction enzymes. 
B. Results and Discussion 
1. Oligonucleotides. Chemical synthesis of DNA has progressed very 
rapidly over the past five years. Fully protected nucleotide precursors have 
emerged; coupling reactions and reagents have been optimized -- typical 
nucleotide condensations exhibit coupling yields of greater than 9596 -- solid 
state synthesis technology has matured, and deprotection/purification 
schemes have been simplified.35-39 
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With the commercial availability of solid state supports, protected 
dinucleotides, and appropriate coupling agents, it is possible to synthesize and 
purify approximately one milligram of a 15 nucleotide sequence within a 
period of two weeks.4-0 This ease and speed of solid state DNA synthesis 
makes the technology an attractive route for the synthesis of an 
oligonucleotide-EDT A. In fact, there are several obvious strategies for 
appending an EDT A to a synthetic oligonucleotide. 
After careful consideration of the chemical details of solid state 
synthesis, it was decided that an 11 nucleotide sequence of thymines would be 
appropriate for a first attempt at synthesizing an an oligonucleotide-EDT A. 
The sequence, dT 11, minimizes chemically incompatible reactions and 
provides a simple substrate for the development of new chemistry. What 
remained was the solution for attaching EDT A to an oligonucleotide. 
(a) EDT A-(triethyl ester)-l mono-N-(3-hydroxypropyl)amide l in the 
Design of an Oligonucleoltide-EDT A. Initially, it was thought that an EDT A 
could be introduced as a pho~phorylated EDT A-(triethyl ester)- (mono-N-
(3-hydroxypropyl)amide), 2. With this unit the EDT A could be coupled to the 
oligonucleotide via known condensation technology; however, attempts to 
synthesize either the fully protected unit, 3, or the corresponding acid, 2, 
from the EDT A-triester-monoamide, 1, were unsuccessful. The reactions 
produced a myriad of inseparable and unidentifiable products. 
The next scheme involved the in situ coupling of EDT A-triester-
monoamide, 1, to dT 11 via the chlorophosphate of 1. After isolation of the 
nucleotide products and cleavage of the ethyl esters, the dT 11-EDT A was 
assayed for cleavage activity. Unfortunately, end labeled dA20 was not 
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degraded by the purported dT 11-EDT A·Fe(II). Since properly delivered 
EDTA·Fe(II) is known to nick DNA, it was concluded that the EDTA did not 
couple to the oligonucleotide. 
(b) Phosphorylate Linkers in the Design of an Oligonucleotide-EDT A. 43 
With the failure to introduce EDT A-linker as a complete unit, the design of 
the oligonucleotide-EDT A was modified to allow the linker and the EDT A to 
be appended to the oligomer in separate operations. For this purpose the 
phosphorylated linker, N-(4,4'-dimethoxytrityD-5-aminopentyl-1-(0-2-chloro-
phenyl)phosphate (4) was synthesized. The linker is easily coupled to a 
supported oligonucleotide, and known condensation chemistry gives coupling 
yields of greater than 85%. 
In a first attempt to couple an EDT A to the linker, the linker-dT 11 
was deprotected, and the solid supported free amine was treated with the N-
hydroxysuccinimide ester of EDT A-triethyl ester. The oligonucleotide was 
then removed from the support, and the nucleotide fractions were treated 
with LiOH. Purified cleaving agent was then assayed with dA2o, but no 
appreciable activity was observed. 
If the EDT A could be coupled to the linker after the oligonucleotide 
has been removed from the support, protected linker-dT 11 may be separable 
from other nucleotide products. Unfortunately, the dimethoxytrityl group is 
extremely labile and is lost during the cleavage of the oligomer from the 
solid support. Without the trityl group, separation of the linker-oligomers 
from smaller oligonucleotides by reverse phase high pressure chromatography 
is no longer possible; consequently, the total mixture of purified oligomers 
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The nucleotide fractions recovered from the reaction were treated with LiOH 
and assayed for activity. In this case, a more sensitive assay was adapted 
from Sanger methodology and relied upon the truncation of DNA synthesis by 
runoff at the site of nicking on a single stranded DNA substrate. 4-2,4-3 The 
assay, however, was poorly chosen and gave ambiguous information. 
To improve the cleavage assay it was necessary to switch to a 
substrate that was commercially available ·as both single stranded and double 
stranded DNA. M 13 mp8 was the logical choice. As a consequence, dT 11 was 
no longer useful, and the oligonucleotide, 5'cGGGAATTCGT3', was chosen to 
replace it. 
The heterogeneous 11 mer forms a more stable double helix than dT 11; 
as such, the llmer might provide a more positive delivery of an appended 
EDT A·Fe(II). The disadvantage of the heterogeneous 11mer is the 
introduction of a reaction to deprotect the cytosines, guanines and adenines. 
Hot concentrated ammonium hydroxide is not compatible with an ester. The 
EDT A-triester must either be hydrolyzed before the sequence is deprotected 
or be appended to the oligomer after the basic hydrolysis. In either case, the 
latitude in introducing the EDT A chelator is seriously constricted. 
Further improvements to the design of the experiment were confined 
to the linker. Monomethoxytrityl was substituted for the dimethoxytrityl 
protecting group. The linker, N-(4--monomethoxytrityl)-5-aminopentyl-1-(0-
2-chlorophenyl)phosphate, 5, could be coupled to the oligonucleotide in 
greater than 95% yield. Analysis of the products suggested that 
approximately 50% of the nucleotide fraction bore a linker, but even though 
the mon.:>methoxytrityl group was stable to both the cleavage from the solid 
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support and the basic deprotection reaction, the protected linker-oligomer 
still could not be purified by reverse phase high pressure chromatography. 
Apparently, the columns catalyzed the release of the trityl group. 
Again, the total nucleotide fraction was treated with the N-hydroxy-
succinimide ester of EDT A-triethyl ester, and the oligomers were purified 
from the reaction. The products were then subjected to 0.25 M LiOH and 
assayed for activity. The llmer-EDT A was annealed to a single stranded end 
labeled fragment of M 13 mp8, and Fe(II)/dithiothreitol were added to induce 
cleavage of the DNA. Specific strand scission would produce a discrete set 
of fragments on a high resolution polyacrylamide denaturing gel, but all that 
was observed was random nicking. 
The failure of the 11mer-EDTA led to a modification of the EDT A 
coupling reaction. Instead of appending the EDT A in the last construction, 
the chelator would be attached to the oligonucleotide and deprotected before 
the reagent was cleaved from the solid support. For this purpose the N-
hydroxysuccinimide ester of EDT A-triethyl ester was replaced with the 
dianhydride of EDT A. Further modifications included the shortening of the 
linker to bring the EDTA closer to the DNA helix. 
The new linker N-(4-monomethoxytrityl}-2-aminoethyl-1-(0-2-chloro-
phenyl)phosphate, 6, could be coupled to the supported llmer in greater than 
90% yield. The linker was then deprotected with ZnBr2, and the free amine 
was allowed to react with excess EDT A dianhydride. After hydrolysis of the 
substrate bound anhydride the reagent was cleaved from the support and 
deprotected with NH40H. Purified oligomer was finally assayed for activity, 
however, the M 13 mp8 assay showed only random cleavage. 
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To determine where problems were arising, the synthesis was repeated 
with 14C labeled EDT A dianhydride. Tracer analysis of the product fractions 
indicated that EDTA was incorporated in less than 5% yield. Fortunately, the 
tagged product could be enriched by gel permeation chromatography. The 
enriched fractions appeared to contain 50% 11mer-EDT A, but assays of these 
fractions again showed only random strand scission. 
(c) Alternative Cleaving Agents in the Design of Functionalized 
Oligonucleotides. Frustration with the oligonucleotide-EDT A syntheses led 
to the examination of two alternative cleaving agents. The first alternative 
utilizes a phenanthroline chelator in place of EDT A, while the second 
alternative employs liganded ruthenium in place of iron. 
The strategy for coupling a phenanthroline to an oligonucleotide is 
exactly analogous to the coupling of an EDT A to an oligomer, but in this case 
there are no protecting groups to interfere with the nucleotide synthesis. 
Diimidazole activated 2-carboxy-1 ,1 0-phenanthroline, 7, was allowed to react 
with the ethylamine linker of a heterogeneous llmer. The oligonucleotides 
were isolated and assayed, but the purported llmer-phenanthroline gave no 
specific cleavage of the end labeled DNA substrate. 
The second strategy makes use of ruthenium(II) pentamine. Like 
Fe(II), Ru(II) is capable of nicking DNA, but unlike iron, ruthenium can be 
directly bound to a variety of nitrogen functional groups. In fact, ruthenium 
pentamine binds the N7 of guanine; consequently, ruthenium can be bound to 
DNA by simply soaking the nucleic acid in an aqueous solution of ruthenium 
pentamine. With this procedure, ruthenium was liganded 
to5'CGGGAATTCG13'. It was hoped that the oligonucleotide would 
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specifically deliver the ruthenium to the target substrate, but in actuality, it 
was found that the functionalized oligomer no longer formed a stable double 
helix and did not deliver the ruthenium to the target. 
2. EDTA-dUTP. In a last effort to design a controlled site DNA 
cleaving agent, the synthetic routes were abandoned and a scheme exploiting 
commercially available enzymes and recombinant methodology was adopted. 
It is well known that DNA polymerases will accept a wide variety of 
nucleotide triphosphates for polymerization into DNA. Langer, Waldrop and 
Ward demonstrated that biotinylated-deoxyuridine-5'-triphosphate (Bio-dUTP) 
is an acceptable substrate for DNA polymerase I and is efficiently 
incorporated into nicks or gaps in double stranded DNA. 44 If an EDT A could 
be attached to deoxyuridine-5'-triphosphate (dUTP) the cleaving agent might 
be delivered to its substrate by direct polymerization of the modified 
nucleotide into DNA. 
EDT A-dUTP (EdUTP) was synthesized by coupling the N-hydroxy-
succinimide ester of EDT A-triethyl ester to 5-(3-aminoallyl) deoxyuridine-5'-
triphosphate, triethylamine salt (AA-dUTP) in dimethylsulfoxide. 
(EtO)JEDT A-dUTP (EEdUTP) could then be purified from the reaction 
mixture by gradient elution from a DEAE A25 Sephadex column. Analysis of 
the triphosphate fractions by high pressure reverse phase chromatography 
revealed that the compound was 90 to 95% pure. It was then shown that 
EEdUTP was an acceptable nucleotide triphosphate for large fragment DNA 
polymerase I. 
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Hind III site of M13 mp8, and the Hind III/Bgl I fragment was isolated. The 
fragment was then treated with pH 11 LiOH to cleave the esters of EEdUTP. 
After annealing the cleavage probe to an M13 mp8 Eco RI/Bgl I fragment 
that had been 5' labeled at the Eco RI restriction, Fe(II) and DTT were added 
to the reaction to induce cleavage of the DNA. Specific strand scission 
would show discrete fragments approximately 30 base pairs long; 
unfortunately, only random background cutting was observed. 
To improve the sensitivity of the experiment the assay was repeated 
with T4 polymerase. The polymerase was allowed to cut back from the Hind 
III site of M 13 mp8 and the single stranded "gap" was refilled. This procedure 
replaced 20 to 40 nucleotides. The Hind III/Bgl I fragment was again isolated 
and the probe was assayed against the labeled substrate. Once more, only 
random background cleavage was observed. 
C. Summary 
The compounds methidiumpropyl-EDT A, distamycin-EDT A, and penta-
N-methylpyrrolecarboxamide-EDT A are three representative examples of a 
class of rationally designed DNA cleaving agents. By appending an iron 
chelator to different DNA binding vehicles the properties of a cleaving agent 
can be controlled. Methidium propyl-EDT A randomly single strand nicks 
DNA with high efficiency. Distamycin-EDT A nicks at 5 base pair recognition 
sites, and penta-N-methylpyrrolecarboxamide-EDT A double strand cleaves 
DNA at 6 base pair recognition sites. With the success of these compounds, a 
site controlled cleaving agent was envisioned. Maybe an EDT A could be 
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directly attached to a short length of DNA. 
The first attempt at synthesizing an oligonucleotide-EDT A was 
designed around known nucleotide triester technology. A small length of 
single stranded DNA can be easily synthesized by solid state techniques. 
There are also a few obvious synthetic routes that might allow the sequence 
to be capped with an EDT A. The failure here to synthesize an active 
oligonucleotide-EDT A does not directly reflect on the viability of the 
cleaving agent, it simply suggests that known synthetic technology is 
inadequate for the synthesis of an oligonucleotide EDT A and that new 
chemistry must be developed to positively construct the nucleotide delivered 
cleaving agent. 
The second approach to the problem of a controlled site cleaving agent 
is not totally synthetic. EEdUTP can be synthesized from EDT A triethyl 
ester and 5-(3-aminoallyl)deoxyuridine-5'-triphosphate. The EEdUTP can 
then be enzymatically incorporated into a short strand of DNA to produce a 
DNA-EDT A cutting probe. Immediate assays of the cleaving agent were 
again negative, but in the long term an extended analysis of the methodology 
for handling EEdUTP may eventually turn up a protocol for creating an active 
cutting probe. 
In conclusion, this investigation has not closed the door on the 
synthesis of controlled site cleaving agents. The logic behind the designs of 
an oligonucleotide-EDT A or a DNA-EDT A still appears to be sound. What 
needs to be solved are the methods of the synthetic execution and the 
techniques for the direct physical characterization of the "synthesized" 
cleaving agents. 
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Materials and Methods 
Oligonucleotides. The oligonucleotides, dT 11 and 5'CGGGAATTCGT3', 
were synthesized via solid state triester technology as described by Tan et. 
al. 40 The solid support was obtain from Vega Biochemicals, while the 
protected dinucleotides and the coupling agent, 1-(mesitylene-2-sulfonyl)-3-
nitro-1,2,4-triazole, were purchased from P-L Biochemicals. The remaining 
reagents and solvents were supplied by J. T. Baker, Aldrich or Fluka. 
EDTA-(triethyl ester)-( mono-1-(3-hydroxypropyl)amide ), 1. A 
solution of 5.7 g EDT A triethyl ester (1 00 mol %), 45 4.2 g 1-
hydroxybenzotriazole (Aldrich, mp 155-1580C, 200 mol %), and 2.3 g 3-
amino-1-propanol (Fluka >97%, 200 mol %) in 40 mL of dry tetahydrofuran 
(THF) was cooled to 5°C in a three-neck 100 mL round-bottom flask that had 
been fitted with an argon inlet and sealed with two septum stoppers. 4.7 5 g 
of N,N'-dicyclohexylcarbodiimide (Aldrich 99%, 150 mol %) were dissolved in 
20 mL THF, and the solution was syringed into the round-bottom flask. The 
reaction was stirred for 40 min at 5oc and was then allowed to warm to room 
temperature. After 24 h the reaction was filtered, and the THF was 
evaporated. The EDT A-( tr iethy 1 ester)- ( mono-N-(3-hydroxypropy !)amide ) , 
was purified from the reaction mixture by step elution (5% to 55% THF in 
dichloromethane over 10% increments of THF) of the product from silica gel, 
230 to 400 mesh (Sigma or Woelm Pharma). Repurification of 2 on silica gel 
(eluent = 7% ethanol in dichloromethane) yielded 5.3 g (80%) of pure 
material. IR (neat) Figure 15; NMR (CDClJ) 0 4.2 (q, 6H, J =7Hz, CH2), 
3.9-3.3 (m, 12H, CH2), 2.8 (s, 4H, CH2), 1.7 (q, 2H, J = 6 Hz, CH2), 1.2 (t, 9H, 
J = 8 Hz, CH2). 
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Elemental analysis calcd. for C 19H35N308: C, 52.64; H, 8.14; N, 
9.69. Found: C, 52.27; H, 7 .96; N, 9.69. 
EDTA-dTtl· Ten milligrams of polystyrene supported dT11 was 
deprotected with ZnBr2 to expose the 5' hydroxyl function. The resin was 
washed with 1 mL of dry THF four separate times (4 x 1 mL THF), and after 
drying the resin under reduced pressure the reaction was covered with argon. 
Meanwhile, 100 mg 2 were dissolved in 0.5 mL CH2Cl2. 67 mg 2-
chlorophenyl dichlorophosphate (Fluka, 110 mol %) were added to the CH2Cl2 
solution, and the reaction was stirred for 15 min. 
The phosphoprylated EDT A was syringed over the dT 11 resin, and the 
mixture was allowed to stand for 1 h. After removing the coupling solution, 
the support products were washed with 3 x 1 mL CH2Cl2, 1 x 1 mL pyridine, 
5 x 1 mL 15% isopropanol in CH2Cl2 and 4 x 1 mL THF. The nucleotide 
products were hydrolyzed off the support and the purported EDT A-llmer was 
precipitated from ethanol and was redissolved in 0.25 M LiOH. Twelve hours 
later the hydrolysis solution was neutralized and the oligomer was 
reprecipitated. The pellet yield 2 OD units of nucleotide 
oligomers (A max = 264 nm). The fraction was then assayed for specific 
cleaving activity on dA20· 
N-(4,4'-dimethoxytrityl)-5-amino-1-pentanol. In a 100 mL three-
necked round-bottom flask equipped with an argon inlet and sealed with two 
septum stoppers, 1.0 g 5-amino-1-pentanol (Fluka 97%, 165 mol%) and 0.73 g 
triethylamine (Baker, 120 mol %) were dissolved in 50 mL isopropanol . 
(Baker). 2.0 g 4,4-dimethoxytrityl chloride (Aldrich 98%, 100 mol %) were 
added to the flask, and the reaction was stirred for 10 h. The volume of the 
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solution was reduced to approximately 10 mL, and the reaction was poured 
into 250 mL of ethyl ether. The ethereal solution was extracted with 1 x 250 
mL 1 N NaOH and 2 x 250 mL water. The organic layer was dried over 
Na2S04, and the solvent was evaporated. Trityl-linker was purified from the 
reaction by column chromatography. Elution of the product from silica gel, 
230-400 mesh, with 20% hexane in diethyl ether gave 1.84 g (77%) of pure 
protected linker. IR (neat) Figure 16; NMR (CDC13) 8 7.5-6.7 (m, 13H, 
aromatic), 3.6 (s, 6H, CH3), 3.5 (t, 2H, J = 5 Hz, CH2), 2.1 (t, 2H, J = 5 Hz, 
CH2), 1.8 (s, 2H, OH and NH), 1.4 (m, 6H, CH2). 
Elemental analysis calcd. for C26H31N03: C, 77.00; H, 7.71; N, 
3.45. Found: C, 77 .02; H, 7 .70; N, 3.51. 
N-(4,4'-dimethoxytrityl)-5-aminopentyl-1-(0-2-chlorophenyl) Phosphate, 
4. In a dry 50 mL three-neck round-bottom flask equipped with an argon inlet 
and two septum stoppers, 257 mg dry 1 ,2,4-triazole (Fluka >99%, 110 
mol %) and 343 mg triethylamine (100 mol %) were dissolved in 20 mL dry 
THF. 416 mg 2-chlorophenyl dichlorophosphate (100 mol %) were syringed 
into the reaction flask. After vigorously stirring the reaction for 1 h, the 
solution was filtered, and the filtrate was transferred to a second three-neck 
reaction flask. A 2 mL solution of 491 mg N-(4,4'-dimethoxytrityl)-5-amino-
1-pentanol in dry THF was added to the phosphorylation reaction, and the 
solution was again stirred for 1 h. 2 mL of 1 M triethylammonium carbonate 
buffer, pH 7 .5, were then added to the reaction mixture, and after 5 min the 
solution was poured into 150 mL of dichloromethane. The dichloromethane 
was extracted with 3 x 150 mL of water and was, subsequently, dried over 
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further dried by co-evaporation with pyridine. The product was dissolved in a 
minimal volume of dichloromethane. 4 was then precipitated from solution 
by the slow addition of the dichloromethane solution to 200 mL of 1% 
triethylamine in pentane. Typical reactions gave yields in excess of 90%. IR 
(KBr) Figure 17; NMR (CDC13) 8 7.7-6.7(m, 17H,aromatic),3.9(q,2H,J =6 
Hz, CH2), 3.8 (s, 6H, CH3), 2.1 (t, 2H, J = 6 Hz, CH2), 1.4 (m, 6H, CH2), 
triethyl amine signals occur at 8 3.0 and 1.2; M/e- = 594 (4: free anion). 
5-Aminopentyl-1-dT 11· N-( 4,4'-dimethoxytrityl-5-aminopentyl-1-(0-2-
chorophenyl) phosphate was coupled to the 5' hydroxyl of solid supported dT 11 
with the same procedures that Itakura uses to introduce a nucleotide. 
Itakura's methodology was not modified at all. 
To obtain the solid supported free amine the dimethoxytrityl function 
was removed by treatment of the resin bound material with ZnBr2. The 
nucleotide is not cleaved from the resin until the EDT A is coupled to the 
molecule. 
In contrast the alternative solution chemistry dictates that the 
protected 1inker-dT 11 be removed from the resin before the trityl group is 
cleaved. Protected linker dT 11 can then be separated from contaminating 
oligomers by reverse phase chromatography, since the trityl function retards 
the elution of the dinucleotide; however, analysis of the nucleotide fractions 
on an Altex C-18 column, 1.0 em x 25 em, by a 20 min 20-30% acetonitrile 
gradient in 100 mM triethylammonium carbonate buffer, pH 7.5, at 1.5 mL 
per min indicated that the dimethoxytrityl protecting group was not present. 
The trityl group had been lost. It then became necessary to accept the 5-
aminopentyl-1-dT 11 without further purification. Nevertheless, th~ linker-
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dT 11 was treated with acetic acid to insure the complete deprotection of the 
amine. 
EDT A, Triethyl Ester, mono-N-Hydroxysuccinimide Ester (EDT A 
(OEt)JNHS). In a septum stoppered vial, 200 mg EDT A, triethyl ester were 
dissolved in 2.5 mL THF or DMSO. 103 mg 1,1-carbonyldiimidazo1e (Aldrich, 
mp 118-1200C, 120 mol %) were added to the vial, and the reaction was 
allowed to stir for 1 h. 91 mg of dry N-hydroxysuccinimide (Aldrich 97%, 150 
mol %) we then added to the reaction. After 12 h of stirring, the activated 
EDT A triester was then transferred into the coupling reaction. EDT A 
(0Et)3NHS cannot be isolated, the compound decomposes during 
chromatography. 
EDT A-dT 11· Supported Substrate Coupling. A 2.5 mL solution of 130 
mg of EDT A (OEt)3NHS was syringed onto supported amino-dT 11· After 24 h 
the resin was washed with 4 x 1 mL THF and the DNA was removed from the 
solid support. The oligonucleotides were precipitated, treated with 0.25 M 
LiOH, and reprecipitated. The purported EDT A-dT 11 was then assayed with 
dA20· 
Solution Coupling. 5-Aminopentyl-dT 11 was dissolved in pyridine, and 
50 mg of EDT A (OEt)3NHS in 1.5 mL pyridine were added to the reaction. 
After 24 h the pyridine was evaporated, and the residue was redissolved in 
water. The DNA was precipitated from the aqueous solution, and the pellet 
was treated with 0.25 M LiOH. The hydrolysis solution was then neutralized, 
and the EDT A-dT 11 was assayed by polymerase extension. 
N-(4-monomethoxytrityl}-5-amino-1-pentanol. The synthesis of N-(4-
monomethoxytrityl-5-amino-1-pentanol duplicates the synthesis of N-(4,4'-
-123-
dimethoxytrityl}-5-amino-1-pentanol. In the end, silica gel chromatography · 
of the crude reaction mixture with 30% hexane in diethyl ether gave an 87% 
yield of pure material. Reagents: 4-monomethoxytrityl chloride (Aldrich 
97%). IR (neat) Figure 18; NMR (CDC13) 8 7.6-6.7 (m, 4H, aromatic), 
3.7 (s, 3H, CH3), 3.6 (t, 2H, J = 6 Hz, CH2), 2.1 (t, 2H, J = 6Hz), 1.4 
(m, 6H, CH2). 
Elemental analysis calcd. for C25H29N02: C, 79.97; H, 7 .78; N, 
3.73. Found: C, 79.62; H, 8.11; N, 3.56. 
N-(4-monomethoxytrityl}-5-aminopentyl-1-(0-2-chlorophenyl) Phos-
phate, 5. Compound 5 was synthesized with the same procedure as was 
described for N-(4,4'-dimethoxytrityl}-5-aminopentyl-1-(0-2-chlorophenyl) 
phosphate. Yield= 91%. IR (neat) Figure 19; NMR (CDCl3) 8 7.6-6.7 
(m, 18H, aromatic) 3.9 (q, 2H, J = 6Hz, CH2), 3.7 (s, 3H, CH3), 2.2 (t, 2H, J = 
6 Hz, CH2), 1.4 (m, 6H, CH2), triethyl amine appears at 8 3.0 and 1.2; 
M/e+ = 667 [ 5·H+-N(Et)3]. 
EDT A-pentyl-5'CGGGAA TTCGT3' (EDT A-llmer). N-( 4-monomethoxy-
trityl}-5-aminopentyl-1-(0-2-chlorophenyl) phosphate was coupled to the solid 
supported oligonucleotide, 5'HO-CGGGAATTCGT3', by typical nucleotide 
triester chemistry. The nucleotide products were cleaved from the solid 
support and treated with concentrated NH40H. The NH40H was evaporated, 
and the residue was redissolved in 0.3 mL H20. One-third of the oligonucleo-
tide solution was purified by elution of the DNA from a G50 Sephadex column 
with 100 mM triethylammonium carbonate buffer, pH 8.'J. A 10 microliter 
aliquot of the chromatographed oligomers was dissolved in 0.2 mL H20, and 
the optical density of the solution was measured at 260 nm. A second 10 
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microliter aliquot was dissolved in 60% HCl04 in ethanol and the optical 
density of the solution was measured at 470 nm. Comparison of the OD260 
against the OD470 showed that approximately 55% of the oligonucleotide 
fraction carried a trityl function; however, further purification of protected 
linker-llmer was impossible. The trityl function was not stable to aqueous 
chromatography on a high pressure reverse phase column. 
The sephadexed fractions were then treated with 80% acetic acid to 
remove the monomethoxytrityl protecting group. The acetic acid was 
evaporated, and the DNA was redissolved in triethylammonium carbonate 
buffer, pH 7 .8. The aqueous solution was extracted with 3 x 1 mL diethyl 
ether, and the water was evaporated. The DNA was dissolved in 50 
microliters H20, and was added to a 0.25 mL solution of 50 mg 
EDT A(OEt)3NHS in DMSO. 10 microliters triethylamine were than added to 
the reaction to scavenge excess acid. After 24 h the EDT A(OEt)3-llmer was 
isolated from the reactiqn by G50 sephadex chromatography. The isolated 
nucleotide fractions were treated with 0.25 M LiOH for 12 h. The hydrolysis 
solution was subsequently neutralized, and the EDT A-llmer was assayed for 
activity after hybridization to an end labeled M 13 mp 8 fragment. 
N-(4-monomethoxytrityl}-2-aminoethanol. N-( 4-monomethoxytr ity 1}-
2-aminoethanol was synthesized by the procedure described under N-( 4,4'-
dimethoxytrityl}-5-amino-1-pentanol; however, the product was isolated 
from the reaction mixture by chromatography on silica gel, 230-400 mesh, 
with a different solvent then described previously. Elution with 70% 
hexane/25% diethyl ether I 5% ethanol gave an 83% yield of protected 
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NMR (CDCl3) o 7.6-6.7 (m, 14H, aromatic), 3.8 (s, 3H, CH3), 3.7 (t, 2H, J = 6 
Hz, CH2), 2.3 (t, 2H, J = 6 Hz, CH2), 1.9 (s, 2H, NH and OH). 
Elemental analysis calcd. for C22H23N02: C, 79.25; H, 6.95; N, 
4.20. Found: C, 79.09; H, 7 .25; N, 4.14. 
N-(4-methoxytrityl}-2-amino-1-ethyl-{0-2-chlorophenyl) Phosphate 6. 
The synthesis of compound 6 was an exact duplication of the synthesis of N-
( 4,4'-dimethoxytr ityl}-5-amino-1-pentyl-( 0-2-chlorophenyl) phosphate 4. 
Yield: 75%; IR (KBr) Figure 21; NMR (CDC13) o 7.8-6.7 (m, 18H, 
aromatic), 4.1 (q, 2H, J = 6 Hz, CH2), 3.7 (s, 3H, CH3), 2.3 (t, 2H, J = 6 H, 
CH2), triethylamine appears at o 2.9 and 1.2; M/e+ = 625 ( 6·H+ 
-N(Et)3)· 
EDT A-ethyl-5'CGGGAA TTCGT3' (EDT A-e-llmer). N-(4-mono-
methoxytrity1}2-aminoethyl-1-(0-2-chloropheny1) phosphate was coupled to 
supported 5'HOCGGGAA TTCGT 3' by conventional nucleotide triester 
chemistry. The monomethoxytrityl group was then removed with ZnBr2, and 
the resin was dried. In a bullet vial, 20 mg of supported linker-llmer was 
suspended in a solution of 40 mg EDT A dianhydride46 in 0.8 mL DMSO. 50 
microliters triethylamine were added to the reaction, and the vial was heated 
to 37oc. After 24 h, the coupling solution was filtered off, and the resin was 
washed with 2 x 1 mL pyridine and 5 x 1 mL THF. The supported product was 
then resuspended in aqueous DMSO and the reaction was incubated at 37°C 
for 15 h. The DMSO was filtered off and the resin was rewashed with 3 x 1 
mL THF. The EDT A-e-llmer was then removed from the solid support, and 
the oligomers were treated with NH40H. Oligonucleotides were then 
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cleaving activity against M 13 mp8 substrate. 
This synthesis was repeated with 14c labeled EDT A dianhydride, and 
the G50 sephadex column was monitored by 14c activity and optical density. 
Total l4C activity indicated that the reaction yielded less than 5% coupling; 
however, the labeled EDT A-e-llmer was enriched in early column fractions. 
14c to optical density ratios suggested that one fraction carried an EDT A on 
50% of the oligonucleotides. This fraction was subsequently assayed against 
Ml3 mp8 substrate. 
14c-EDTA Dianhydride. 46 In a 3 mL vial, 50 microcuries EDT A-
(acetic-2-14c) and 245 mg EDT A were suspended in a solution of 0.25 mL 
acetic anhydride (Mallinkrodt) and 1.25 mL pyridine. The reaction was 
heated to 65°C and was left stirring for 24 h. The solids were then filtered 
away from the reaction solution and were washed with 2 x 1 mL pyridine. 
The labeled EDT A dianhydride was then dried under reduced pressure. 
Analysis of the labeled dianhydride yielded a specific activity of 
78 llCi/mmol. 
1,10-Phenanthroline-ethyl-5'cGGGAATTCGT3'. N-(4-monomethoxy-
trityl}-2-aminoethyl-1-(0-2-chlorophenyl) phosphate was coupled to supported 
5'HOCGGGAA TTCGT3' by conventional nucleotide triester chemistry. The 
monomethoxytrityl function was then removed, and the supported linker-
llmer was dried. 
Meanwhile, 50 mg 2-carboxy-1,10-phenanthro!ine47 and 36 mg 1,1-
carbonyldiimidazole were dissolved itl 1.5 mL pyridine. The reaction was 
allowed to stir for 1 h, and was subsequently syringed over the supported 
linker-llmer. After 24 h, the reaction solution was withdrawn, and the resin 
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was washed with 4 x 1 mL THF. The oligonucleotides were cleaved off the 
resin and were deprotected in NH40H. The NH40H was evaporated and the 
residue was redissolved in water. The reaction mixture was then fractionated 
by G50 sephadex chromatography, and the purported phenanthroline-e-Umer 
was assayed against M13 mp 8 substrate. 
5'cGGGAA TTCGT3'-ruthenium Pentamine. The oligonucleotide was 
synthesized and purified according to the procedures of Tan et al. 40 1.2 OD 
units of llmer were dissolved in 0.4 mL water. The sample was then dialyzed 
against pH 3 HCl in 2-200 microliter dialysis buttons. The buttons were then 
suspended in a 100 mL three-neck round-bottom flask. The flask was 
equipped with a glass stopper and suspension hook, an argon inlet, a gas outlet 
and a magnetic stirring bar. 50 mL pH 3 HCl were added to the round-
bottom flask and the solutio.n was deoxygenated by bubbling argon through 
the solution for 30 min. 0.2 g of fresh Hg-Zn amalgam were added to the 
flask, and argon was bubbled through the flask for an additional 30 min. 10 
mg Cl(NH3)5RuCl2 were added to the flask, and the reaction was stirred 
under positive argon pressure for 22 h. The dialysis buttons were then 
removed from the round-bottom flask and were successively dialyzed against 
pH 3 HCl and 40 mM Trizma/HCl pH 7 .8. The llmer-Ru oligonucleotide48,49 
was then assayed against M13 mp 8 substrate. Additional analyses 
demonstrated that the llmer-Ru would not serve as a primer for large 
fragment polymerase, presumably, the oligonucleotide does not form a stable 
DNA double helix. As such the oligonucleotide cannot deliver the chemically 
active ruthenium. 
5-(3-Amino)allyldeoxyuridine-5'-triphosphate (AAdUTP). 44 700 mg 5-
-132-
mercurideoxyuridine-5'-triphosphate50 were dissolved in 50 mL 0.1 M NaOAc 
buffer, pH 5. The solution was transferred into 100 mL three-neck round-
bottom flask. The flask was equipped with an argon inlet, addition funnel, 
glass stopper, and magnetic stirring bar. The 50 mL solution was cooled to 
5°C in an ice bath, and 6 mL of freshly neutralized 2 M allylamine was added 
to the reaction flask -- allylamine is neutralized by adding 3 mL allyamine to 
17 mL 4 M acetic acid. 280 mg of K2PdCl4 were dissolved into 8 mL water, 
and the solution was slowly dripped into the stirred solution of HgdUTP and 
allylamine. The ice bath was then allowed to melt. The reaction was then 
left to stir at room temperature for 36 h. Afterward, the reaction was 
filtered through a 0.5 micron filter, and the filtrate was diluted to 300 mL 
with water. The reaction solution was loaded on a 150 mL DEAE A-25 
Sephadex column that had been prev_iously equilibrated with 0.1 M, pH 5, 
NaOAc. The column was then flushed with one volume of 0.1 MpH 5, NaOAc 
and was subsequently eluted with a 1.1 liter linear gradient (0.1-0.7 M) of 
triethylammonium carbonate (TEAB), pH 7 .8. The AAdUTP eluted at 
approximately 0.3 M TEAB and fractions with absorption maxima greater 
than 285 nm were collected. 
redissolved in 10 mL H20. 
The TEAB was evaporated, and the residue was 
The AAdUTP was then collected by ethanol 
precipitation from 0.4 M NaOAC, pH 7. The synthesis yielded .... 250 mg 
of pure AAdUTP ( .... 30%). 
EDTA(OEt)JdUTP (EEdUTP). 660 mg EDT A-triethylester were 
dissolved in 6.0 mL dry DMSO, and the solution was transferred into a 25 mL 
round-bottom flask. 490 mg 1,1-carbonyldiimidazole (170 mol %) were added 
to the flask, and the reaction was stirrt:d for 1 h. 450 mg N-hyroxy 
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succinimide (220 mol %) were then added, and the reaction was stirred 
overnight. 
85 mg AAdUTP, triethylamine salt, were dissolved in 5.0 mL DMSO, 
and the solution was pipetted into the reaction flask. 0.5 mL triethylamine 
were syringed into the solution, and the reaction was stirred for 24 h. 
Afterward, the reaction was diluted with water to a volume of 100 mL, and 
the solution was loaded on a 100 mL DEAE A-25 sephadex column. The 
column was washed with one column volume of 0.1 M TEAB, pH 7 .6, and 
eluted with an 800 mL linear gradient (0.1-0.7 M) of TEAB. The major 
fraction eluted at approximately 0.4 M TEAB. Analysis of the fraction by 
high pressure liquid chromatography (column: Whatman ODS-2; solvent: 0.5 
M AcO-HN+Et3, pH 4.3) showed that no starting material was present, and 
that the EEdUTP was 95% pure. The compound was then assayed for cleaving 
activity. IR (KBr) Figure 22; NMR (06-DMSO) Figure 23; M/e+ = 906 
(EEdUTP·Na·5 H+ = fully protonated). 
dA20 Cleavage Assay. dA20 was 5' end labeled with ( y_32p)-
A TP. The molecule to be assayed and an aliquot of dA20 were dissolved in 10 
microliters of 20 mM Trizma/HCl, pH 7 .4, 50 mM NaCl (TN). The nucleic 
acid was then annealed by slowly cooling the samples from 90°C to 4°C over 
2 h. One microliter 2 x l0-4 M Fe(NH4)2(S04)2 was added to the samples and 
the reactions were equilibrated for 1 h. One microliter 50 mM dithiothreitol 
(OTT) was then pipetted into the samples, and the cleavage reaction was run 
for 2 h. 
The samples were then denatured with formamide at 90°C, and the 
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gels. Specific activity would be characterized by efficient cleavage of the 
dA20· 
Polymerase Extension Cleavage Assay. An M 13 mp9 clone obtained 
from Richard Firtel contained the Eco RI/Hind III fragment of the discoidin 
lA gene. This sequence harbors a string of 30 adenines approximately 180 
nucleotides from the primer site for Sanger sequencing. If a cut is made in 
the string of 30 adenines, polymerase extension of Sanger sequencing primer 
should truncate at the cleavage site that ends the sequence. 
An aliquot of dT11-EDTA was annealed to the M13 mp9 clone in 10 
microliters of TN buffer. A microliter of 1 x 1 o-4 M Fe(NH4)2(S04)2 was 
added to the vials, and the sam pies were equilibrated for 1 h. Finally, one 
microliter of 50 mM DTT was added to the mixtures, and the samples were 
allowed to stand for 2 h. 
Afterwards, the samples were ethanol precipitated and redissolved in 
polymerase buffer. A Sanger sequencing primer (New England Biolabs) was 
then annealed to the clone, and ( a_32p) dATP, dGTP, dCTP, and dTTP 
were added to the sample. One unit of large fragments polymerase was 
allowed to extend the Sanger primer for 20 min. In the last 5 min of the 
polymerase reaction , cold dATP was added to the mixtures to complete DNA 
synthesis. 
The samples were denatured with formamide at 9QOC, and were 
electrophoresed on a 8% acrylamide denaturing gel. The gel was visualized 
by autoradiography. Specific cleavage should produce a discrete 180 nucleo-
tide fragment; unfortunately, complications and background make this assay 
useless. 
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Ml3 Cleavage Assay. Sixteen micrograms of M 13 mp8 RF were 
restricted with Hind III and the plasmid was 3' end labeled with large 
fragment polymerase and ( a.-32p) dATP. The M13 was re-restricted with 
Pvu II and the DNA was electrophoresed down an 8% acrylamide gel. The 208 
bp fragment was cut from the gel, and the labeled fragment was eluted from 
the gel slice with 1 mL 0.5 M NH40Ac, 10 mM Mg2+, 2 mM EDTA and 0.1% 
sodium dodecyl sulfate. The DNA was then purified by millipore filtration 
and precipitation. 
Four milliroentgen labeled DNA, 0.5 micrograms single stranded M13 
mp 8, and 5 equivalents of cutting agent were annealed from 90°C in 15 
microliters 20 mM Trizma/HCl (pH 7 .4), 50 mM NaCl and 1 x 10-5 M 
Fe(NHtt)2(SOtt)2· One microliter 50 mM DTT was added to the vials after the 
solution had cooled to room temperature (._, 1.5 h), and the reactions were 
then allowed to stand for 2 h at room temperature. The samples were then 
denatured with formamide at 900C, and the DNA was analyzed by electro-
phoresis on a 20% acrylamide denaturing gel. The "sequencing gel" was then 
visualized by autoradiography. Specific cleavage would produce fragments 
approximately 25 nucleotides long. 
EDTA-dUTP Cleavage Assay. (a) EEdUTP was initially tested with 
large fragment polymerase to determine if the modified triphosphate could 
be incorporated by the polymerase. Two micrograms pBR322 were restricted 
with Sal I. The DNA was split into two samples. The first vial was doped 
with dUTP, ( a.-32p) dCTP, dGTP and dATP, while the second vial was laced 
with EEdUTP, ( a._32p) dCTP, dGTP and dATP. Large fragment polymerase 












ends of the restriction. If EEdUTP is not a substrate for large fragment 
polymerase, radiolabeled dCTP will not be incorporated. Autoradiography of 
a 5% polyacrylamide gel showed that the two samples that had been run on a 
gel contained approximately equal amounts of radiolabel in the pBR322. 
EEdUTP is apparently a legitimate nucleotide precursor for large fragment 
polymerase. 
(b) Cleavage Assay.51 Ten micrograms M13 mp8 RF were restricted 
with Eco RI and 5' end labeled with ( y_32p) ATP. The plasmid was 
restricted with Bgl I, and the labeled 179 nucleotide strand was isolated from 
an 8% acrylamide denaturing gel. After precipitation, the DNA was dissolved 
in 0.1 mL TN buffer. 
A second lot of 10 micrograms of M13 mp8 RF was restricted with 
Hind III. The sticky ends of the plasmid were filled by polymerase in the 
presence of EEdUTP. The DNA was re-restricted with Bgl I, and the sample 
was electrophoresed through an 8% acrylamide gel containing 0.5 
micrograms/mL ethidium bromide. The 149 base pair fragment was isolated 
from the gel and treated with pH 11 LiOH for 4 h. After precipitation, the 
DNA was redissolved in 0.1 mL TN. 
Five microliters of labeled fragment and five microliters of "cutting 
probe" in 30 microliters TN were annealed from 9QOC over 1.5 h. Three 
microliters of 2.5 x 1Q-4 M Fe(NH4)2(S04)2 were added to the samples, and 
the reactions were allowed to equilibrate for 1 h. OTT, 3.0 microliters of a 
50 mM solution, was added to the vials, and the solutions were incubated at 
370C for 2 h. The samples were lyophilized and afterward were redissolved 
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and analyzed by electrophoresis through a 20% acrylamide denaturing gel. 
Specific cleavage should produce a fragment approximately 30 nucleotides 
long. 
(c) An Alternative Cutting Probe. A cutting probe to increase the 
sensitivity of the cutting assay was synthesized with T4 polymerase. Ten 
micrograms of Ml3 mp8 RF was restricted with Hind III. Ten units of T4 
polymerase were then added to the DNA solution, and the polymerase was 
allowed to hydrolyze the 3' ends of M13 mp 8. After a 2 min incubation at 
37°C, EEdUTP, dA TP, dGTP and dCTP were added to the reaction, and the 
polymerase was allowed to refill the ends of the linearized plasmid. The 60 
min incubation at 370C was followed by a 10 min incubation a 700C to 
denature the polymerase. The DNA was re-restricted with Bgl I, and the 149 
bp cutting probe was isolated, deprotected, and assayed as described in part 
(b). In this case, specific activity would be ·characterized by fragmentation 
of the 32p labeled DNA at adenines 30-70 nuc!eotides from the Eco RI end of 
fragment. 
Recombinant DNA Methodology. 52 All techniques needed for the 
handling and manipulation of DNA are described in detail in "Molecular 
Cloning: A Labor a tory Manual". 
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